SlideShare a Scribd company logo
1 of 312
.
Medical surgical nursing
By Dawit Tesfaye(Bsc, MSC)
General objective
• After completion of this course, the student
will be able to assess, diagnose and manage
patients with medical surgical disorders
related to GIT , GUT and musculoskeletal
disorders and / or refer those requiring higher
level of management.
Contents
• Unit 1: Gastrointestinal tract (GIT) disorders
• Unit 2: Genito urinary tract (GUT) disorders
• Unit 3: Musculoskeletal system disorders
.
References:
1) Donna D. IGNATAVICIUS. A Nursing Process
approach Medical surgical
2) Medical surgical Brunner 11th Edition
3) Lackman and Sorensson medical surgical
nursing
4) Sharon medical surgical Nursing
5) Harrison’s principle of internal Medicine 16th
edition
Management of patients
with Gastro intestinal tract
(GIT) disorders.
5`
Anatomy and physiology
• The GIT tract is pathway (23-to-26 feet or 7-8
meter in length) that extends from the mouth
through the esophagus, stomach and
intestines to the anus.
• It also includes organs that lie out side the
digestive tract i.e. pancreas, liver and gall
bladder.
6
Mouth and related structures'
• Digestion normally begins in the mouth,
Mouth and related structures includes
• Mucus membranes of the mouth
• Teeth
• Gums
• Lips
• Soft and hard plates
7
Fig. Mouth and related structures
8
Cont---
 Esophagus: is located in the mediastinum in
the thoracic cavity anterior to the spine and
posterior to the trachea and heart.
• Length: 23-25 cm (10 inch).
• At the upper end of the esophagus there is a
sphincter i.e. upper esophageal sphincter.
9
Cont---
10
Cont---
Stomach
• Location: is situated in the upper portion of the
abdomen to the left of the midline.
• Capacity: about 1500ml.
11
Cont----
• The stomach can be divided in to four
anatomic regions
The cardia (entrance)
Funds
Body and
pylorus (outlet)
12
Fig. anatomical regions of the stomach
13
Cont---
• The inlet of the stomach is called the
esophagogastric junction.
• In the inlet there is lower esophageal
sphincter (or cardiac sphincter).
• In the out let: pyloric sphincter.
14
Cont---
Small intestine : is the longest segment of
the GI tract accounting for about 2/3 of the
total length
• Length: 5-6meters (16-19 feet)
• It is divided in to three anatomic parts
• The upper part, called the duodenum,
• The middle part called the jejunum and
• The lower part called the ileum.
15
Cont---
The large intestine: consists of
– ascending colon
– transverse colon
– Descending colon
16
Cont---
Cecum: is found in junction between the
small and large intestine.
• Is located in the right lower portion of the
abdomen.
• The ileocecal value is located at this junction.
• The vermiform appendix is located near this
junction.
17
Cont---
The terminal portion of the large intestine
consists of two parts
• The sigmoid colon and the rectum
• The rectum is continuous with the anus.
18
Cont---
19
Function of the Digestive system
– To breakdown food particles in to the molecular
form for digestion
– To absorb the small molecules in to the blood
stream, produced by digestion
– To eliminate undigested and unabsorbed food
stuffs and other waste products from the body.
i.e. secretion, digestion, absorption, motility and
elimination.
20
Diagnostic test for common GIT
problems
I) Radiography:
• Is a simple x-ray without contrast agents.
• It shows obstruction or paralysis of the
digestive tract or abdominal air patterns in
the abdominal cavity .
• Also shows enlargements of organs like liver.
21
Cont---
II) Barium studies
• Entire GI tract can be out lined using a
contrast agent such as barium sulfate.
 Barium swallow: ingested orally
 Barium enema: instilled rectally
22
Cont---
III) Endoscopic procedures
• Examination of internal structures using a
viewing tube /endoscope.
• Many endoscopes have small scissors to
remove tissue sample and electric probe to
destroy abnormal tissue.
23
Cont---
A) Esophago gastro duodenoscopy (EGDS)
• Allows for direct visualization of esophageal, gastric,
and duodenal mucosa through a lighted endoscopy.
• Used for both diagnosis and treatment purpose.
• Pt NPO b/r and after the procedure.
• Local anesthetic sprayed is indicated.
• Position : left lateral.
24
Cont---
25
Cont---
B) Laparoscopy
• Insert through the skin in the abdominal wall
under spinal or general anesthesia.
• Used to screen for tumor or other
abnormalities, to obtain sample, and to
examine any organ in the abdominal cavity
26
Cont---
C) Proctoscopy and sigmoidoscopy
• used to inspect/examine the rectum and
sigmoid colon respectively for the evidence
of ulceration, tumors, polyps, and other
abnormalities
D) Colonoscopy
• Examine the colon to the cecum
27
Cont----
28
Cont---
29
Cont---
IV) Gastric analysis
• Small tube into the stomach to obtain a fluid
sample.
• Stomach contents are aspirated by suction
into the syringe
• May be performed to diagnose gastric CA
30
Cont---
V) Stool examination
• Inspected for color, and consistency.
• If blood is lost large amount in the upper GIT
blood produce a tary black color/ Melena.
• If blood entering the lower portion of GIT
(passing rapidly through) it will appear bright
or dark red.
31
Cont---
• If there is streaking of blood on the surface of
the stool or if blood is noted on the toilet i.e.
lower rectal or anal bleeding is suspected.
• N.B. fecal occult blood test (FOBT) is a
common stool test to detect for CA(GI
bleeding associated with colorectal cancer)
32
Assessment
Health history and clinical manifestations
• The nurse begins by taking a complete history,
focusing on symptoms common to GI
dysfunction
33
Cont---
symptoms include: -
Pain - can be major symptoms
- Notify - the character
- location
- Duration
- Frequency
- Time of the pain
- Underline cause
34
Cont---
35
Cont---
• Indigestion - due to disturbed nerves control of the
stomach
• Intestinal “Gas" (Belching and flatulence)
• Accumulation of gas in GIT may result belching
• Vomiting
• Hematemesis - vomiting of blood : bright red or
coffee ground appearance
36
Cont---
• Diarrhea - abnormal in stool liquidity
• Constipation - difficult defecation.
 Physical assessment
• The Physical examination includes
assessment of the mouth, abdomen and
rectum.
• Inspection ---- auscultation --- percussion ----
palpation.
37
Cont---
38
Problems of oral related structures
• Adequate nutrition is related to good dental
health and the general condition of the mouth,
because digestion normally begins in the
mouth.
• Changes in the oral cavity may influence the
type and amount of food ingested as well as
the degree to which food particles are
properly mixed with salivary enzymes.
39
Cont---
40
A) Oral candidiasis /Trush
• Cheesy white plaque that looks like milk curds
w/n rubbed off it leaves erythematous and
often bleeding base.
• Is caused by fungus.
• Candida albicans is the most common agents
of candidiasis.
• Is the common form of candidiasis
41
Predisposing factors
Poor oral hygiene
Chronic illness like DM, HIV
Immunosuppressive therapy e.g. radiation
steroid therapy
Long term antibiotic therapy.
42
Fig. oral candidacies
43
Cont---
44
Cont---
 S/ Sx
–Cheesy white plaque
–Erythematous /reddened/and often
bleeding gums.
 Mgt
–Antifungal medications
Nystatin
Clotrimazole or ketokonazole
45
Complication
• Esophageal candidiasis
• Oral cancer
• Systemic candidiasis (life threatening)
46
B) Leukoplakia
 Chronic inflammation with thick patches on
mucous membrane.
 Slowly developing changes in the oral
mucosa membrane that are characterized by
thickened white, firmly attached patches.
47
Cont---
• White patches usually on the tongue, gums,
and inside of checks.
• 90% of leukoplakia lesions are benign,
however, up to 7% of lesions becomes
malignant after many years.
• Lesions on the lips and tongue are more likely
to progress to malignancy
48
Fig. Leukoplakia
49
Fig. Leukoplakia con’t
50
Causes
• Chronic irritation of the mouth (e.g. poorly
fitting dentures, broken or poorly repaired
teeth)
• Smoking, infected teeth.
• Very spicy foods
• Immunosuppressant e.g. HIV
• N.B. it can confused with oral Candidal
infection however, leukoplakia can’t removed
by scraping.
51
Cont---
• Hairy" leukoplakia of the mouth is an unusual
form of leukoplakia that is seen mostly in HIV-
positive people.
• It may be one of the first signs of HIV
infection.
52
Fig. Hairy leukoplakia
53
Symptoms
• The most common symptoms of hairy
leukoplakia are painless, fuzzy /hairy white
patches on the side of the tongue.
• The skin lesions tend to have the following
characteristics:
• Location
– Usually on the tongue
– May be on the inside of the cheeks
54
Cont---
• Color
– Usually white or gray
– May be red (called erythroplakia, a condition that
can lead to cancer)
• Texture
– Thick
– Slightly raised
– Hardened surface
55
Management
• Removing the source of irritation is important and
may cause the lesion to disappear.
• Treat dental causes such as rough teeth, irregular
denture surface, etc
• Stop smoking and do not drink alcohol.
• Some times surgery may require to remove the
lesion.
56
Prognosis
• Lesions often clear up in a few weeks or
months after the source of irritation is
removed.
57
C) Stomatitis
• Is also called canker sore
• Shallow ulcer with a white center and red border
• The sore usually forms on the soft, loose tissues
particularly on the inside of the lips or cheek,
tongue, soft palate and sometimes in the throat.
• It is very common (affecting 20% of the general
population to some degree)
• Episode occurs 3-6 times per year
58
Cont---
• It can be:
 small or
large canker sore
59
Possible causes
 Vitamin deficiency (B-
complex, folic acids,
Zink, iron)
 infection (bacterial, viral
or fungus)
 systemic diseases (HIV,
DM, leukemia)
 irritants ( tobacco, and
alcohol)
Chemotherapy or
radiation therapy.
allergies, acidic foods
it is also associated
with emotional or
mental stress,
fatigue, or hormonal
factors and genetic
predisposition
60
Sign and symptoms
• No detectable systemic
symptoms of or signs
out side the mouth
• pain lasts 4-10 days
• Fever and dry mouth
• Shallow ulcer with or
gray center and red
border.
• It begins with burning,
itiching or tingling
sensation and slight
swelling
• Tongue may be dry,
cracked, contain masses
or exudates.
• Sensitivity to hot and
spicy foods.
• Oral bleeding
61
Mgt
• Control or remove
causes
– Improve diet
– Rx treatment of
underlying infections
with Abs.
• Good oral hygiene
 Medications
• Analgesics for pain,
• Topical/systemic
steroids
62
Cont---
Antimicrobials (to treat as well as to prevent
secondary infection)
• Abs
E .g. TTC syrup 250/10ml QID for 10 days.
• Antiviral:
 IV acyclovir (infused at constant rate over a
1hr period every 8hrs for 7days
• Antifungal
• Rest: to promote tissue repair 63
Reading assignment
Disorders of teeth gums & salivary gland
–Gingivitis
–Dental plaque and caries/cavities
–Periapical abscess
–Parotits
–Oral cancer
64
Esophageal disorders
There are many pathologic conditions of the
esophagus, including:
• Esophagitis
• Motility disorders
• Hiatal hernias, and
• Diverticula,
65
A) Esophagitis
• Is an acute or chronic inflammation of the
esophagus.
• It also called gastro esophageal Reflux disease
(GERD).
66
Causes
• Gastro esophageal
reflux
– Inappropriate relaxation
of LES.
– Delayed gastric emptying
– Medication that reduces
strength of LES (like OCP,
nitrates, sedatives, B-
blockers, calcium
channel blockers and
anticholinergics)
• Trauma
– Swallowing of foreign
bodies
– Prolonged Naso - gastric
intubation
– Repeated vomiting
• Infection
• Chemicals: acids, alkalis
67
C/M
• Dyspepsia/indigestion
• Heart burn
• A sensation of acidic or
bitter regurgitation
associated with nausea
• Bleeding (acute or
chronic
 Dysphagia or
odynophagia (pain on
swallowing)
 Pain on
drinking/alcohol, hot or
cold fluid
 Worsen w/n the client
bends over, strain, or in
recumbent position.
68
Diagnosis
• Using c/m
• Esophagoscopy
69
Management
• Depends on the cause of esophagitis
1) life style changes
– The patient is instructed to eat slowly and chew
foods thoroughly (to avoid belching )
– avoid caffeine, beer /alcohol and smoking,
– Avoid acidic foods e.g. orange juice, tomatoes etc.
– Raising the head of the bed /15-20cm
70
Cont---
- Remain upright 1-2hrs after meal
- No food or drink with in 2-3hrs of bed time
- Avoid lifting of heavy objects or straining and
working in bent over position.
- Avoid heavy meal / Eat a low-fat diet
- Encourage small and frequent diet 4-6 times
than large foods 3 times /day
- N.B. left lateral position reduces GER!
71
Cont---
2) Chemotherapy
• Antacids after each meal and before bed time.
• Accelerate gastric emptying e.g.
metoclopramide /prokinetic drugs
• Anti secretory agents
• Antibiotics if associated with infection
72
2) Achalasia
• Is a motility disorder.
• Is absent or ineffective peristalsis of the distal
esophagus accompanied by failure of the
esophageal sphincter to relax in response to
swallowing.
73
Cont---
• Narrowing of the esophagus just above the
stomach results in gradually increasing
dilation of the esophagus in the upper chest.
• The exact cause is unknown
74
Cont---
75
c/m
• Difficulty in swallowing ( both liquid and
solid): The 1st symptom
• Sensation of food sticking in the lower portion
• Food is commonly regurgitated,
• May have chest pain and heart burn
• Halitosis (unpleasant-smelling breath)
• Pain may or may not be associated with eating
76
Diagnostic Evaluation
• Radiological studies - show esophageal
dilation above the narrowing at the gastro
esophageal junction
• Barium swallow and endoscopy may be used
to diagnosis.
• c/ms
77
Management
• Patient should be instructed to eat slowly and
to drink fluids with meals and avoid foods that
aggravate the condition.
• Mild cases can be treated with Ca++ channel
blockers and nitrates have been used to
decrease lower esophageal pressure and
improve swallowing.
78
Cont---
• If this is unsuccessful
• pneumatic (forceful) dilation: by passing a
tube into the esophagus i.e. large metal stents
maybe used to keep esophagus open for
longer duration.
• Has 75% success rate and a 3% incidence of
perforation
79
Fig. Dilation of narrowed
esophagus
80
Cont---
• Surgical separation of the, muscle fibers may
be recommended /esophagomyotomy /LES
incised.
81
Fig. LES incision
82
C) Esophageal Diverticula /pouches
• Diverticulum: is an out pouching of mucosa
and sub mucosa that protrudes through a
weak portion of the musculature.
• Esophageal diverticula: is a sacs resulting
from the herniation of esophageal mucosa
and sub mucosa into the surrounding tissue.
83
Cont---
It may occur in one of the three areas of the
esophagus:-
• The pharyngo - esophageal or upper area of
the esophagus (most common)
• The mid esophageal area or
• Epiphrenic or lower area of the esophagus
84
Cont---
85
Cont---
86
C/M
• Difficulty swallowing
• Fullness in the neck
(feeling that food stops
before reaching in to
the stomach)
• Belching
• Halitosis
• Regurgitation of
undigested foods
• Diverticulum /pouch
filled with food or fluid
87
Dx
• Esophago gastro dodunoscopy after barium
swallow.
88
Management
• The only means of cure is surgical removal of
the diverticulum /diverticullectomy
• After surgery foods and fluids are withheld
until x-ray is confirm no leakage at surgical
site.
89
Gastric and duodenal disorders
A) Gastritis
Inflammation of the gastric or stomach
mucosa
 it is a common GI problem.
It may be acute, lasting several hours to few
days, or chronic , resulting from repeated
exposure to irritating agents or recurring
episodes of acute gastritis.
90
Cont---
Acute gastritis : inflammation of the gastric
mucosa after exposure to local irritants.
Causes:
• is often caused by dietary indiscretion.
• The person eats too much or too rapidly or
eats food that is contaminated or too highly
seasoned or is infected.
91
Cont---
• Other cause includes – alcohol, aspirin, bile
reflux, or radiation , infection (staph, strep, E.
coli, salmonella. )
• More severe form of acute gastritis is caused
by ingestion of strong acids or alkalis
• Gastritis also may be the 1st sign of an acute
systemic infection
92
Cont---
 C/M - Acute gastritis
• Rapid onset of gastric
pain or discomfort
• Dyspepsia /heart burn
• Abdominal discomfort
• Headache
• Nausea, anorexia
• Vomiting /
hematemesis
• Some patients,
however, are
asymptomatic.
93
Cont---
Chronic gastritis
– Prolonged inflammation of the stomach may be
caused by either benign or malignant ulcers of the
stomach or by the bacteria helicobacter pylori.
– Appears as a patchy diffuse/spread out
inflammation of the mucosal lining of the
stomach.
94
Cont---
• it may also be associated with dietary factors such as
hot drinks or spices, use of drugs, alcohol, smoking
or reflux of intestinal contents in to the stomach.
95
Cont---
C/ms of chronic gastritis.
• Heartburn/ epigastric pain
• Anorexia
• Belching
• Sour taste in the mouth
• Vomiting and nausea
• Pernicious anemia
96
Cont---
Diagnosis
• History
• Hyper chlorhydria
• Endoscopy
• X-ray
• Serologic test (H.pylori )
97
Management
• The gastric mucosa is capable of repairing itself after
a bout of gastritis
• Avoid foods /drinks that cause distress coffee, tea
,chocolate, alcohol and smoking
• Instruct the patient to refrain from alcohol and food
until symptoms subside.
• Encourage nonirritating diet
• Bed rest
98
Cont---
for Chronic gastritis
• is managed by modifying the patient’s diet
• promoting rest,
• reducing stress and
• initiating pharmacotherapy (antacids,
sucralfate, and Abs)
99
Nursing intervention
• Assess and document signs and symptoms and
reactions to treatments
• Monitor intake and out put.
• Provide the prescribed diet.
• Administer medication as prescribed and monitor for
side effects.
• Note amount and character of emesis and diarrhea
and Monitor IV fluids.
• Educate patient and family concerning drug therapy,
diet activities and any restrictions.
100
B) Peptic ulcer diseases (PUD)
• A peptic ulcer is an excavation (hollowed-out area)
that forms in the mucosal wall of the stomach, in the
pylorus (opening between stomach and duodenum)
in the duodenum or in the esophagus.
• It is frequently referred to as gastric, duodenal or
esophageal ulcer, depending on its location or as a
peptic ulcer disease.(PUD)
101
Cont---
102
Cont---
• Erosion of a circumscribed area of mucus
membrane is occurred.
• This erosion may extend as deeply as the
muscle layers or through the muscle to the
peritoneum
• Peptic ulcers are more likely to be in the
duodenum than in the stomach,
103
Fig. Gastric and duodenal ulcer
104
Cont---
105
Cont---
Incidence:
• Has greater frequency occurrence b/n ages of
40 and to 60 hrs
• Relatively uncommon in women child bearing
ages i.e. man to women ratio 3:1
• Man to women ratio after menopause 1:1
106
Cont---
Causes:
• Increase secretion of Hcl and pepsin acid or
• Decrease in the normal resistance of the
mucosa.
• Gram-negative bacteria H. pylori
107
Cont---
Predisposing factors
• Stress (occupational stress ,and emotionally stress
• Emotional tense persons/anger
• Hereditary link persons with Blood group O are 35%
more susceptible than others
• Other predisposing factors associated with peptic
ulcer include caffeine, smoking, alcohol ingestion,
chronic use of NSAIDS
108
Pathophysiology
• The erosion is due to an increase in
concentration or activity of acid – pepsin or
due to a decrease in the normal resistance of
the mucosa.
• A damaged mucosa is unable to secrete
enough mucus to act as a barrier against HCl
acid.
109
Cont----
• When a break in mucosal barrier; the Hcl
injuries the epithelium.
• Rapidly emptying of food from stomach
reduces the buffering effects of food and
delivers a large acid bolus to the duodenum
leading to duodenal ulcer.
110
Clinical manifestation
• Symptoms ulcer may last for a few days,
weeks, months may even not disappear.
• Dyspepsia/ indigestion: discomfort centered
around the epigastrium or upper abdomen is
the most common reported symptoms
111
Cont---
• Pain – dull, gnawing(cramp) pain, or a burning
sensation in the mid epigatrium or in the back.
• It is believed that pain occurs w/n there is increased
acid content of the stomach and duodenum.
• Sharply localized tenderness can be elicited by
applying gentle pressure to the epigastrium or
slightly to the right of the midline.
• Some relief is obtained by applying local pressure on
the epigastrum.
112
Cont---
• Pyrosis(heart burn): some patients experience
a burning sensation in the esophagus and
stomach.
• Vomiting : is rare in uncomplicated duodenal
ulcers.
• Constipation and bleeding: perforation or
hemorrhage may occur with any preceding
manifestations.
• Abdominal distention/fullness.
113
Comparing Duodenal and Gastric Ulcer
 Duodenal Ulcer/DU
Incidence
• Age 30-60
• Take 80%
• hyper secretion of HCL
 Gastric Ulcer/GU
• Usually 50 and above
• 15% of cases
• Normal-hypo secretion
of HCL
114
DU GU
• Pain occurs after 2-3hrs
of a meal
• Ingestion of food relives
pain
• May have wt gain
• Vomiting uncommon
• Pain occurs ½ to 1hr
after a meal ;may
relived by vomiting
• Ingestion doesn’t help,
sometimes it may
increase pain;
• Weight loss may occur
• Vomiting common
115
DU GU
• Hemorrhage less likely
than with G.U
• But if present, melena
is more common than
hematemesis
• More likely to perforate
than G.U
• Malignancy : rare
• Hemorrhage more likely
to occur than with
duodenal ulcer;
• Hematemesis more
common than melena
• less likely to perforate
• Malignancy:occasionally
116
Diagnostic Evaluation
• History and physical examination/bowel
sound may be absent
• C/ms: Pain relived by ingesting food or
antacids – suggestive of duodenal ulcer.
• Barium study of the upper GI tract may show
an ulcer - X-ray
117
Diagnosis Cont---
• Endoscopy: is the preferred diagnostic procedure to
detect those lesions not evident in x ray studies b/c
of the size and location of lesions.
• Stool- for occult blood
• Gastric secretion studies
• Serologic test for antibodies of H.pylori Ag.
118
Management of PUD
A) Nondrug management
• Stress reduction and rest
• Smoking cessation
Dietary modification: avoid foods that
increase secretion of acid e.g. coffee, alcohol,
cola, cram, milk,
119
Cont---
• Small and frequent foods
• Food it self acts as an antacid by neutralizing
gastric acid for 30-60 minutes then an
increased gastric secretion follows.
• Follow up care
120
Cont---
B) Drug mgt
I) Antacids
• Magnesium hydroxide and or Aluminum
hydroxide 50-80 MEq 1hr and 3 hr after meal
and at bed time.
121
Cont---
II) H2 Receptors antagonist
• Cimetidine : 300mg PO Qid for 4-6 week (400mg
BID and 800 mg once)
• Ranitidine : 150 mg PO BID for 4-6 week (300mg PO
at bed time)
• Famotidine : 40 mg po once a day for 4-6 week
• Nizatidine : 150 mg PO BID or 300mg at bed time.
122
Cont---
III) Antisecrotary agents
• Omeprazole 20mg PO BID or 40mg at bed time
• Lansoprazole 15 or 30 mg PO at bed time.
• Panto prazole 40mg PO IV daily
• Esomeprazole 20mg or 40 mg PO daily.
IV) Mucosal barrier fortifiers
• Sucralfate 1gm PO QID or 2gm twice daily.
123
Cont---
.
V) Antimicrobes
• Clarithromycin 500 mg PO TID
• Amoxicillin 1 gm PO BID
• TTC 500 mg PO QID
• Metrindazole 250 mg PO TID at bed time.
124
Cont---
PUD associated with H. pylori
• First line: Amoxicillin 1gm PO BID +
clarithromycin 500 mg PO BID + omeprazole
20mg PO BID or 40mg once daily.
• Alternative: amoxicillin + metrindazole 500mg
PO BID + omeprazole
125
Cont---
C) Surgical management
• Surgical intervention for peptic ulcers is less
common
• It usually recommended for patient with
intractable ulcers, life threatening
hemorrhage, perforation, obstruction
126
Cont---
It includes:
A) Vagotomy: Severing of the vagus nerve.
Decreases gastric acid by diminishing
cholinergic stimulation to the parietal cells,
making them less responsive to gastrin.
 reduce gastric acid secretion
127
Fig. Vagotomy
128
Cont---
B) Billroth I : antrectomy with anastmosis to the
duodenum / gastro- duodenostomy
• Removal of the lower portion of the antrum of
the stomach (which contains the cells that
secrete gastrin) as well as a small portion of
the duodenum and pylorus.
• The remaining segment is anastomosed to the
duodenum (Billroth I)
129
Fig. Gastroduodenostomy
130
Cont---
c) Billroth II: antrectomy with anastmosis to the
jejunum /gastro- jejunostomy.
• Removal of distal third of stomach;
anastomosis with jejunum.
• Removes gastrin -producing cells in the
antrum and part of the parietal cells
131
Fig. Gastrojejunostomy
132
Cont---
• Potential complications
– Hemorrhage
– Perforation
– Pyloric obstruction (it occurs when the area distal
to the pyloric sphincter becomes scarred and
stenosed from spasm or edema)
– Intractable ulcers (hard to control)
133
C) Gastric Cancer
• Mostly occurs in people over age of 40 and
occasionally in younger people.
• Most stomach cancers occur in the lesser
curvature , pylorus or antrum of the stomach
and are adenocarcinomas
• The tumor infiltrates the surrounding mucosa,
penetrating the wall of the stomach &
adjacent organs and structures
134
Cont---
• The liver, pancreas, esophagus and duodenum are
often affected at the time of diagnosis.
• Diet appears to be a significant factor. i.e. a diet high
in smoked foods and low in fruits & vegetables may
increase the risk of gastric cancer.
• Other factors related to the incidence of gastric Ca
include chronic inflammation of the stomach,
pernicious anemia, achlohydria, gastric ulcers, H.
pylori infection and genetics.
135
Fig. gastric CA
136
Cont---
C/M
• In the early stage of gastric Ca symptoms may
be absent.
 Symptoms of progressive disease may include:
• anorexia( lack of appetite), dyspepsia,
(indigestion), wgt loss, abdominal pain,
constipation, anemia & N/V.
137
Cont---
Diagnostic Evaluation
• P/E is usually not help full, as most gastric
tumors are not palpable
• X-ray with barium swallows.
• Endoscope for Biopsy and cytological study
• Computed tomography (CT) scan
138
Cont---
Management
• There is no successful Rx of gastric carcinoma
except removal of the tumor.
• If the tumor can be removed while it is still
localized to the stomach, the patient can be
cured.
• If the tumor has spread beyond the area –cure
cannot be effective
139
Cont---
Surgical mgt
• Radical subtotal gastrectomy - the stump of
the stomach is anastomosed to the Jejunum
• Total gastrectomy – GI continuity is restored
by an anastomoiss b/n the ends of the
esophagus and jejunum.
140
Cont---
Other treatment includes
• Chemotherapy
• Radiation has little success in gastric Ca.
141
Cont---
Nursing interventions
1) Preoperative care
• Support the patient and family
• Assess and document signs and symptoms and
reaction to treatments
• Provide and encourage the prescribed diet
• Monitor vital signs at least Q 8 hrs
• Monitor blood and fluid replacement therapy
• Provide preparative teaching
142
Cont---
2) Post operative care
• Have patient turn, cough and breathe deeply
• Monitor NG suctioning and tube patency
• Monitor vital signs as ordered
• Record intake and out put
• Administer prescribed medications and
monitor for side effects
143
Cont ---
• Encourage early ambulation and Rome (rapid
eye movement exercises to prevent
thrombosis
• Provide anti embolism and supportive
measures
• Analgesics if pain occurs, and supportive
measures
• Educate patient and family concerning drug
therapy dietary restrictions, activity,
144
Intestinal disorders
Intestinal Obstruction
• It exists when blockages prevents the normal
flow of intestinal contents through the
intestinal tract.
• Two types of process can impede flow:
1) Mechanical obstruction - an intraluminal
obstruction from pressure on the intestinal
walls.
145
Cont--
 Mechanical obstruction can be caused by:
• Intussusceptions: one part of the intestine
slips in to the another part located below it
like a telescope shortening.
• Adhesions: loops of the intestine become
adherent to areas that heal slowly or scar
after abdominal surgery
146
Cont---
• Volvlus: bowel twist and turns upon it
• Hernias: protrusion of intestine through a
weakened area in the abdominal muscle or
wall.
• Tumors, and neoplasm
147
Fig. Mechanical obstruction
148
Cont---
2) Functional obstruction: the intestinal
musculature cannot propel the contents
along the bowel.
• E.g. muscular dystrophy, endocrine disorders
such as DM, or neurological disorders such as
Parkinson’s disease
149
Cont---
• The obstruction can be partial or complete.
• Its severity depends:
• On the region of bowel affected
• The degree to which lumen is occluded and
• Especially the degree to w/c vascular supply is
disturbed
150
A) Small bowel obstruction (SBO)
• Most bowel obstructions (85%) occur in the
small intestine, Adhesion is the most common
cause of SBO, followed by hernias and
neoplasms.
151
Cont----
Pathophysiology
• In SBO, intestinal contents, fluid, and gas accumulate
above the intestinal obstruction
• The abdominal distension and retention of fluid
reduce the absorption of fluids and Stimulate more
gastric secretion
• This caused edema, congestion, necrosis and
eventually rupture or perforation of the intestinal
wall, with resultant peritonitis.
152
Cont---
• Reflux vomiting may be caused by abdominal
distension
• Dehydration and acidosis develop from loss of
water and sodium.
• With acute fluid losses hypovolemic shock
may occur.
153
Cont---
C/M-
• Initially crampy pain that is wavelike and
colicky.
• blood and mucus may pass, but no fecal
matter and no flatus.
• Abdomen becomes distended
154
Cont---
• If obstruction is complete- the peristaltic wave
become reverse direction so intestinal content come
to the mouth
• If obstructions is in the ileum- fecal vomiting takes
place
• First the patient vomits the stomach contents then
the bile stained contents of the duodenum and the
jejunum and finally with each paroxysm of pain, the
darker, fecal like contents of the ileum.
155
Cont---
 Sign of DHN become evident i.e. intense thirst
• Drowsiness
• Generalized malaise
• abdominal distention
• hypovolemic shock from DHN and loss of plasma
volume and
• constipation
156
Cont---
Diagnostic Evaluation
• patient Hx and P/E
• X-ray findings (shows abnormal quantities of
gas, fluid or both in the bowel)
• Laboratory studies (electrolyte studies and
CBC)
157
Cont---
Management
• Decompression of the bowel through a
nasogastric tube is successful in most cases
• Complete obstruction needs , surgical
intervention /depends on the cause of
obstruction i.e.
– if adhesion dividing the adhesion to which
intestine is attached ,
– if hernia: repairing of hernia.
158
Cont---
• IV therapy to replace the depleted water, and
electrolyte before surgery
• prophylactic antibiotics
• monitor intake and out put
• supportive care
159
Cont---
Nursing intervention
• Maintaining the function of the NG tube
• Assessing and measuring the nasogastric out put
• Assessing for fluid and electrolyte imbalance
• prepare the pt’ for surgery
• Assess and document signs and symptoms and
relations to treatments
• Monitor V/S at least Q 4 hrs
• Record intake and out put
160
Cont---
• Administered prescribed medication and
monitor for side effects
• maintain NPO
• monitor the state of distention and hydrations
• provide routine post operative care if patient
undergoes surgery
161
B) Large bowel obstruction (LBO)
• About 15% of intestinal obstruction occur in
the large bowel and the most common cause
are carcinoma, diverticulitis, inflammatory
bowel diseases and benign tumors
• Most are found in sigmoid colon.
162
Cont----
• As in small bowel obstruction, large bowel
obstruction results in an accumulation of intestinal
contents, fluid and gas proximal to the obstruction.
• Even if the obstruction is complete, it may be
undramatic if the blood supply to the colon is not
disturbed.
• If the blood supply is cut off, however strangulation
and necrosis (i.e. tissue death) occur, this condition is
life threatening.
163
c/ms
• LBO differs clinically from small bowel
obstruction in that Symptoms develop slowly
relative to SBO
• Constipation (if obstruction in sigmoid colon
or the rectum).
• Abdomen becomes markedly distended
164
Cont---
• Loops of large bowel becomes visibly outlined
through the abdominal wall.
• Eventually, Crampy lower abdominal pain
• Dehydration occurs more slowly than in the
small intestine
165
Cont---
Diagnosis
• Based on symptoms
• X-ray studies (show distended colon)
• Barium enema is contraindicated.
166
Cont---
Management
• Colonoscopy may be performed to untwist
and decompress the bowel.
• Rectal tube to decompress.
• The usual Rx, however, is surgical resection to
remove the obstructing lesion.
167
Cont---
• Cecostomy /surgical opening of the cecum /
may be performed.
• Temporary or permanent colostomy may be
necessary /is the surgical creation of an
opening into the colon to drainage or
evacuation colon contents to the outside of
the body.
168
Acute inflammatory intestinal
disorders.
• Any part of the lower gastrointestinal tract is
susceptible to acute inflammation caused by
infection due to bacteria, virus, or fungus.
• The two sever situations are appendicitis and
diverticulitis. And others include peritonitis
and gastroenteritis.
169
A) Appendicitis
• Appendix is a small, finger like appendage about 10
cm long that is attached to the cecum just below the
ileocecal valve
• Has no definite function
• The appendix fills with food and empties regularly in
to the cecum
• Because it empties inefficiently and its lumen is
small, the appendix is prone to obstruction and is
particularly vulnerable to infection.
170
Cont---
• Appendicitis: It is an inflammation of the
appendix.
• Is the most common cause of acute
inflammation in the RLQ of abdominal cavity
• Is the most common reason for emergency
surgery.
• People consume a diet low in fiber and high in
refined carbohydrates are more liable
171
CAUSES OF APPENDICITIS
Traumatic injury to the abdomen
Feces blocks the inside of appendix
Genetics
Genetic variant that predisposes a person to
obstruction of the appendiceal lumen
CAUSES OF APPENDICITIS
Obstruction of the lumen by:
 A fecalith (accumulated feces)
 Foreign bodies
 Worms (e.g., Pinworms, ascaris)
 Intramural thickening caused by lymphoid hyperplasia
 Tumors of the cecum or appendix
 Kinking of appendix
 Inflammation
 Neoplasm
pp
Obstruction

Distension

Venous engorgement

Accumulation of mucus and bacteria (pus)

Gangrene

Perforation
Fig. Appendicitis
175
Cont---
C/M
• Right lower quadrant pain and is usually
accompanied by a low-grade fever and nausea
and vomiting sometimes
• Loss of appetite
• Local tenderness noted in Mcburaey’s point.
(Located ½ way b/n the umbilicus and the
anterior spine of the ileum)
176
Fig. Mcburaey’s point.
177
178
Cont---
• If the appendix is has ruptured, the pain
becomes more diffuse.
• abdominal distention, develops as a result of
paralytic illus .
• Constipation can also occur
• In general, laxative or cathartic should never
be given while the person has fever nausea or
pain.
179
Diagnosis
• Patient Hx
• Lab studies particularly WBC count /elevated
WBC.
• X-ray findings
• Physical examination
180
Cont---
Tests of appendicitis
• Rovsing’s sign
• Rebound tenderness
• Psoas sign
• Obturator sign
181
Pointing sign
182
Psoas Sign: 2 methods
1st Method
 Place your hand just above the patient’s right knee
 Ask the patient to raise that thigh against your hand (extending right
thigh)
2nd Method
 Ask the patient to turn onto the left side
 Then extend the patient’s right leg at the hip
 Flexion of the leg at the hip makes the psoas muscle contract;
extension stretches it 183
184
Rovsing’s sign
• Elicited by palpating the LLQ; this
paradoxically causes pain to be felt in the RLQ
185
Positive Obturator Sign
 Flex the patient’s right thigh at the hip, with the knee bent,
and rotate the leg internally at the hip
 This maneuver stretches the internal obturator muscle
If the appendix has ruptured
 The pain becomes more diffuse
 Abdominal distention develops
 The patient’s condition worsens
186
187
• Blumberg’s sign - The pain is elicited with
pressing the abdominal wall deeply with
fingers and abruptly releasing it.
188
189
• < 4: Excludes diagnosis
• 5-6: Equivocal
• >7 : Strongly s/o appendicitis
• Modified Alvorado Score:
- 9 points
- Differential count not done
190
Tzanakis Score
1. Rt lower abdominal tenderness = 4
2. Rebound tenderness = 3
3. WBC’s> 12,000 in the blood = 2
4. Positive USS findings of appendicitis = 6
• Total score = 15
• > 8 = 96% chances
Management
1) Supportive treatment
• Correct fluid and
electrolyte imbalance
and DHN.
• Antibiotics
• If surgery is undecided
avoid analgesic
2) Surgery: is indicated if
appendicitis is
diagnosed==>appendec
tomy.
192
Cont---
Complications
• The major complication of appendicitis is
perforation of the appendix, which can lead to
peritonitis or abscess.
• Incidence of perforation is 10-32%
• It generally occurs 24hrs after the onset of
pain. Symptoms include a fever of 37.7oC or
higher, and continued abdominal pain or
tenderness.
193
B) Peritonitis
• Peritoneum is the serous membrane lining the
abdominal cavity and covering the viscera.
• Peritonitis is an acute inflammation of the
peritoneum
• It can be classified as primary (as TB) and
secondary (secondary to trauma, bile leakage )
and localized and generalized.
194
Cont---
• It is commonly caused by the leakage of
contents from abdominal organs into the
abdominal cavity, and lead to contamination
of peritoneal cavity by bacteria usually as a
result of inflammation, infection, or trauma
195
Etiology
• Usually it is a result of bacterial infection, the
organism come from disease of the GI tract (
e. coli, streptococcus, staphylococcus, etc )
or, in women, from the internal reproductive
organs (Gonococcus).
• Bacteria gain entry into the peritoneum by
perforation or from external penetrating
wound.
196
Cont---
• The most common causes of bacteria
peritonitis are appendicitis, perforation
associated with PUD, diverticulitis, and bowel
obstruction.
• It can also result from external sources such as
injury or trauma (ex. Gunshot wound, stab
wound), or inflammation that extend from an
organ outside peritoneal area.
197
c/ms
• It depends on the location and extent of
inflammation
• The cardinal signs of peritonitis are
abdominal pain / tenderness localized or
generalized) and progressive abdominal
distention.
• At first, diffuse type of pain is felt
198
Cont---
• The pain tends to become constant, localized
and more intense near the site of
inflammation
• The affected area of the abdomen becomes
extremely tender and distended and the
muscles become rigid.
199
Cont---
others
• fever
• N/V/anorexia
• diminished bowel sounds
• inability to pass flatus and or feces
• pulse rate increase
• Dehydration
• Respiratory difficulty
200
Cont---
Diagnostic Evaluation
• c/ms
• lab, increase WBC(> 20,000/mm3)
• abdominal X-ray
• Peritoneal dialysis (positive for peritonitis if
more than 500 WBC/ml of fluid or more than
50,000 RBCs/ml of fluid or Presence of
bacteria )
201
Management
• Hospitalization
• Fluid, and electrolyte
replacement is the
major focus.
• Iv fluids
• Analgesics are
prescribed for pain
• Broad spectrum
antibiotics therapy
• NG tube is inserted to
decompress the
stomach and intestine
and the client is on NPO
status
• Oxygen if respiratory
distress.
202
Cont---
• Positioning: semi fowlers position to promote
drainage of peritoneal contents in to inferior
region and abdominal cavity and also to it
facilitate adequate respiration.
• Surgical if critically needed: exploratory
laparotomy ; to remove or repair the inflamed
or perforated organ;
203
Cont---
Complication
• Sepsis is the major cause of death from
peritonitis
• Shock – from septicemia or hypovolemia
• Intestinal obstruction – from inflammatory
process 10 from development of bowel
adhesions
204
C) Diverticulitis
• Diverticula are congenital or acquired pouch
like herniations of the mucosa through the
muscular wall of the small intestine or colon.
• Diverticula can occur in any part of the small
or large intestine but they occur most
commonly in the sigmoid colon.
205
Cont---
• Diverticulosis is the presence of many
diverticula without inflammation or
symptoms.
• Diverticulitis is the term used to describe an
inflammation of one or more diverticula,
206
Causes
• It forms when the mucosa and sub mucosal layer of
the colon herniated through the muscular wall
because of
• High intraluminal (abdominal) pressure and
• Decreased muscle strength in the colon wall
(i.e. muscular hypertrophy from hardened fecal
masses or w/n blood supply interrupt ).
• Chronic constipation precedes the
development of diverticulosis by many years
• Eating diet with small fiber can increased the
risk of diverticula. 207
Cont---
• Undigested foods or bacteria can become
trapped in the diverticulum = diverticulum
becomes inflamed and local abscess forms =
diverticulitis
• Abscess develops and may eventually
perforate, = leading to peritonitis
208
Cont---
C/M
• Bowel irregularity and intervals of diarrhea
• Abrupt onset of crampy pain in the LQ
• Fever
• V/N, anorexia and abdominal distension
• Bleeding
• If untreated, septicemia develop
209
Cont---
Dx
• Occult blood test /FOBT
• x –ray
210
Management
• Combination of drug and diet therapy with
rest to decrease inflammation and to
improve tissue perfusion.
• When symptoms occur, rest, analgesics and
antispasmodics are recommended
• Initially, the diet is clear liquid until the
inflammation subsides: then a high fiber, low-
fat diet is recommended.
211
Cont---
• Broad spectrum antibiotics e.g. metrindazole
+ Cotrimoxazole, anti pains and
anticholinergics (to reduce intestinal motility)
are recommended
• enema and laxatives are avoided = increase
intestinal motility
• encourage to avoid activities that increase
abdominal pressure e.g. straining, bending,
lifting etc
212
Cont---
• Surgical management :- immediate surgical
intervention is necessary if complications (Ex.
Perforation/rupture , abscess formation,
hemorrhage, peritonitis and bowel
obstruction)
213
D) Gastro enteritis
• Is an increase in the frequency and water
contents of stool or vomiting as result of the
inflammation of mucous membrane of the
intestinal tract and stomach
• It can be viral (e.g. rota virus) or bacterial ( e.g.
E.coli, shigellosis, ameobiasis,) in origin.
• Usually self limiting if no complication
214
Cont---
Mgt
• Treatment of the c/ms plus
• drug mgt depends on the lab result
• e.g. if bacterial Abs ( Norfloxacillin 400mg PO
BID, or ciprofloxacilin 500mg PO BID for
3days)
• If viral only supportive treatment (Rx of DHN,
antiemetic, anticholenergis to suppress
intestinal motility)
215
Chronic inflammatory Bowel Disease (IBD)
• Is disorders of the lower GIT, and it refers to
two chronic inflammatory GI disorders:-
–Ulcerative colitis
–Regional enteritis (crohn’s disease)
216
A) Ulcerative Colitis
• Is a recurrent ulcerative and inflammatory
disease of the mucosal and sub mucosal layers
of the colon and rectum with unknown
etiology.
• Sometimes following bowel infection,
Autoimmune (antibody against bowel
epithelium) can be a contributory factors
217
Cont---
• It affects the superficial mucosa of the colon
and is characterized by multiple ulcerations,
diffuse inflammations
• Bleeding occurs as a result of the ulcerations.
• The mucosa becomes edematous and
inflamed
• The disease process usually begins in the
rectum & spreads proximally to involve the
entire colon.
218
Cont---
• Is a serious disease accompanied by systemic
complication and high mortality rate.
• Eventually 10-15 % of the pt develop
carcinoma of the colon.
• Peak incidence 30-50yrs.
219
Cont---
C/M
• Diarrhea(10 to 20 times /day),
• LLQ abdominal pain,
• intermittent tensemus and rectal bleeding are
the predominant symptoms.
220
Cont---
Others: May have anorexia, wt loss, fever,
vomiting and dehydration, as well as
cramping, the feeling of an urgent need to
defecate .
• Hypocalcemia & anemia frequently develop.
• Rebound tenderness may occur in the right
lower quadrant (suggests peritonitis)
221
Cont---
Diagnostic evaluation
• Stool is +ve for blood
• Low Hgb and HCT and increases WBC
• X-ray (abdominal)
• Sigmodoscopy, or colonoscopy
• Stool examination for parasites and other
microbes (to rule out dysentery caused by
common intestinal organisms like
E.histolytica) 222
Management
Nutritional therapy
• Oral fluids,high protein, high-calories diet with
supplemental vitamin therapy and iron
replacement are prescribed to meet
nutritional needs, reduce inflammation, and
control pain and diarrhea
• Any foods that exacerbate diarrhea are
avoided ex. Milk, may contribute to diarrhea
in those with lactose intolerance.
223
Cont---
Pharmacologic therapy
• Antidiarrheal & anti peristaltic medications
are used to minimize peristalsis to rest the
inflamed bowel
• Aminosalicylate formulations are often
effective for mild or moderate inflammation
• Corticosteroids are used to treat severe
disease
224
Cont---
• Surgical management may recommend when
medical measurement fail to relive the severe
symptoms.
• e.g. total proctocolectomy /colectomy with
permanent ileostomy =>The colon rectum and
anus are removed and followed by closure of
anus.
225
B) Regional Enteritis /crohn’s disease
• An inflammatory diseases of the small
intestine (60%) and colon or both.
• it involves all layers of the bowel but most
commonly involves the terminal ileum.
• It results in sever diarrhea and mal absorption
of vital nutrients.
226
c/ms
• In RE, the onset of
symptoms is usually
insidious
• abdominal pain and
diarrhea unrelieved by
defecation
• Crampy abdominal pain
• Abdominal tenderness
and spasm
• Since eating stimulates
peristalsis, the crampy
pain occur after meals
• Weight loss as a reason
of to avoids the crampy
pain, malnutrition and
secondary anemia.
227
Mgt
• Similar to UC
228
Comparison b/n RE and UC
Ulcerative colitis
• Begins in the rectum
and proceeds in a
continuous manner
toward the colon
• Etiology: Un known
• 10-20 liquid bloody
stool per day
Regional enteritis
• Most often in the
terminal ileum with
patchy involvement
through all layers of the
bowel
• Un known
• 5-6 soft loose stools per
day rarely bloody
229
Cont---
Ulcerative colitis
• Complications:
Hemorrhage,
perforation, fistula and
nutritional deficiency
Regional enteritis
• Fistula and nutritional
deficiency
230
Cancer of large intestine colon and rectum
• The exact cause of colon and rectal cancer is
unknown.
 but the risk factors including
• family history colon CA,
• history of chronic inflammatory diseases
• Age – over 40 ,
• Diet –high in fat, protein, beef, and low in
fiber .
231
Cont---
Distribution of cancer site throughout the
colon
• 22% in ascending colon,
• 11% transverse colon,
• 6% descending colon,
• 33% sigmoid colon and in 27% rectum
232
Cont---
233
Cont---
234
Clinical manifestations
• Changes in bowel habits
(most common)
• The passage of blood in
the stools (2nd most
common)
• Rectal/ abdominal pain,
• Tensmus and feeling of
incomplete emptying
after bowel mov’t.
 Symptoms may include
also
• Unexplained anemia
• Wt loss , fatigue and
dull abdominal pain
235
Cont---
• N.B any patient with a history of unexplained
change in bowel habit, with passage of blood
in the stools should be studied carefully to
rule out cancer of the large bowel.
236
Diagnostic Evaluation
• Abdominal and rectal examination
• Fecal occult blood testing (most important)
• Procto sigmoidoscopy and colonoscopy with
biopsy or cytological smear)
• X-ray
237
Management
• Chemotherapy (anti carcinogenic drugs: IV-5
fluorouracil (5-FU), with or without Leucovorin ,
potent analgesics)
• Radiation therapy and supportive therapy
• Surgical resection of the affected area with
anastomosis /creation of a colostomy(fecal diversion)
if necessary : permanent or temporarily colostomy,
collectomy (colon removal )
238
Disease of the Anorectum
• Anorectal disorders are common.
It includes
• Anal Fissure
• anal fistula
• Anorectal Abscess and
• Hemorrhoids
239
Anal Fissure
• Is a longitudinal tear or ulceration in the lining
of the anal canal
• They are usually caused by the trauma of
passing a large, firm stool or from persistent
tightening of the anal canal because of stress
and anxiety
240
Cont---
Other causes includes
• Child birth
• Trauma and
• Over use of laxatives
c/ms
• Extreme painful defection, burning and
bleeding characterize fissures.
241
Cont---
• Most of these fissures heal if treated by
conservative measures, w/c include stool
softeners , an increase in water intake, sitz
bath and suppositories.
• If fissures do not respond to conservative Rx,
surgery is indicated.
• The anal sphincter is dilated and the fissure is
excised.
242
Anal fistula
• An anal fistula is a tiny, tubular, fibrous tract
that extends into the anal canal from anal an
opening located beside the anus.
• Fistulas usually result from an infection.
• They may also develop from trauma, fissures
or regional enteritis (RE) and obstructed
labuor in mother
243
C/ms
• Pus or stool may leak constantly from the
cutaneous opening.
• Other symptoms may be the passage of flatus
or feces from the vaginal or bladder
depending on the fistula tract.
• Untreated fistula may cause systemic infection
with related symptoms .
244
Mgt
• Surgery is always recommended.
• Fistulectomy /excision of the fistulous tract
• Keep the pt NPO and rehydrate with IV
245
Hemorrhoids
• Are dilated portions of veins in the anal canal.
• They are very common.
• By the age of 50, 50% of people have
hemorrhoids to some extent
246
Predisposing factors
• Increased intra abdominal pressure in the
hemorrhoid tissue
pregnancy,
constipation,
internal abdominal tumors = pressure in rectal
and anus veins = dilation occurs
247
Cont---
They are classified into two types:-
• Internal hemorrhoids:- if it occurs above the
internal sphincter
• External hemorrhoids: - those appearing
outside the external sphincter.
248
Fig. Internal and external hemorrhoids
249
C/ms
• Hemorrhoids cause itching and pain and are
the most common cause of bright red
bleeding with defection
• Feeling of mass or pressure in the anal canal.
• Edema and inflammation
250
Cont---
• External hemorrhoids: are associated with
severe pain from the inflammation and edema
caused by thrombosis(i.e. clotting of blood
within the hemorrhage)
• Internal hemorrhoids: are not usually painful
until they bleed or prolapsed when they
became enlarged
251
Management
• It can be relieved by good personal hygiene,
and by avoiding excessive straining during
defecation
• A high residue diet and increased fluid intake.
• Laxatives , suppositories
• Warm compress, Sitz bath and bed rest
252
Cont---
Surgical Rx is applied according to the
progress.
• The rubber band legation procedure: the
hemorrhoid portion above the
mucocutaneous lines is grasped with an
instrument and a small rubber band is then
supplied over the hemorrhoids , the tissue
becomes necrotic after several days and
sloughs off.
253
Cont---
• Hemorrhoidectomy, or surgical excision: can
be performed to remove all the redundant
tissue
254
Reading assignment
Hernia
• Inguinal hernia
• umbilical hernia
• Incisional hernia
• Abdominal hernia
• Esophageal / diaphragmatic hernia
255
.
• Group Assignment on Pancreatic, hepatic and
billary disorders
Group Assignment and presentation on
Pancreatic, hepatic and billary disorders
 Group 1 and 6: [Liver]
• Hepatitis
• Liver cirrhosis
 Group 2 and 4 : [Liver and pancreas]
• Liver abscess and
• Pancreatitis
 Group 3 and 5 : [Billary]
• Cholecystitis and
• Cholelithiasis
Outlines of the assignment
• Definition
• Epidemiology
• Pathopsiology (if any)
• Etiology/cause and or risk factors
• Clinical manifestations
• Diagnosis
• Management
• Nursing intervention
• Prevention and control measures
END
Thank you!!!
259
Hepatic disorder
260
261
Jaundice
• When the bilirubin concentration in the
blood is abnormally elevated, all the
body tissues, including the sclerae and
the skin, become tinged yellow or
greenish-yellow, a condition called
jaundice.
• Jaundice becomes clinically evident when
the serum bilirubin level exceeds 2.5
mg/dL. 262
Cont’d…..
• Increased serum bilirubin levels and jaundice may
result from impairment of hepatic uptake,
conjugation ofbilirubin, or excretion of bilirubin into
the biliary system.
• There are several types of jaundice: hemolytic,
hepatocellular, and obstructive jaundice, and
jaundice due to hereditary hyperbilirubinemia.
• Hepatocellular and obstructive jaundice are the two
types commonly associated with liver disease.
263
Hemolytic Jaundice
• Hemolytic jaundice is the result of an increased
destruction of the red blood cells, the effect of
which is to flood the plasma with bilirubin so
rapidly that the liver, although functioning
normally, cannot excrete the bilirubin as quickly
as it is formed.
• This type of jaundice is encountered in patients
with hemolytic transfusion reactions and other
hemolytic disorders.
264
Hepatocellular Jaundice
• Hepatocellular jaundice is caused by the
inability of damaged liver cells to clear normal
amounts of bilirubin from the blood.
• The cellular damage may be caused by hepatitis
viruses, other viruses that affect the liver (eg,
yellow fever virus, Epstein-Barr virus),
medications or chemical toxins (eg, carbon
tetrachloride, chloroform, phosphorus,
arsenicals, certain medications), or alcohol.
265
Obstructive Jaundice
• Obstructive jaundice resulting from
extrahepatic obstruction may be caused by
occlusion of the bile duct from a gallstone, an
inflammatory process, a tumor, or pressure
from an enlarged organ (eg, liver, gallbladder).
Hereditary Hyperbilirubinemia
• Increased serum bilirubin levels
(hyperbilirubinemia), resulting from any of
several inherited disorders, can also produce
jaundice.
266
Portal Hypertension
• Portal hypertension is the increased pressure
throughout the portal venous system that results
from obstruction of blood flow through the damaged
liver.
• Commonly associated with hepatic cirrhosis, it can
also occur with non-cirrhotic liver disease.
• Although splenomegaly (enlarged spleen) with
possible hypersplenism is a common manifestation
of portal hypertension, the two major consequences
of portal hypertension are ascites and varices.
267
Ascites
268
Clinical Manifestations
• Increased abdominal girth and rapid weight
gain are common presenting symptoms of
ascites.
• The patient may be short of breath and
uncomfortable from the enlarged abdomen,
and striae and distended veins may be visible
over the abdominal wall.
• Umbilical hernias also occur frequently in
those patients with cirrhosis.
• Fluid and electrolyte imbalances are common.
269
Management
• Dietary modification- The goal of treatment
for the patient with Ascites is a negative
sodium balance to reduce fluid retention.
Diuretics
• Use of diuretics along with sodium restriction is successful in 90% of
patients with ascites.
• Spironolactone (Aldactone), an aldosterone-blocking agent, is most often
the first-line therapy in patients with ascites from cirrhosis.
• When used with other diuretics, spironolactone helps prevent potassium
loss.
• Oral diuretics such as furosemide (Lasix) may be added but should be used
cautiously, because long-term use may induce severe sodium depletion
(hyponatremia).
270
Bed Rest
• In patients with ascites, an upright posture is
associated with activation of the renin–angiotensin–
aldosterone system and sympathetic nervous system
• This causes reduced renal glomerular filtration and
sodium excretion and a decreased response to loop
diuretics.
• Therefore, bed rest may be a useful therapy,
especially for patients whose condition is refractory
to diuretics.
• Paracentesis
271
Transjugular Intrahepatic Porto systemic Shunt
• TIPS-is a method of treating ascites in which a
cannula is threaded into the portal vein by the
transjugular route (Fig. 39-6).
• Toreduce portal hypertension, an expandable
stent is inserted to serve as an intrahepatic
shunt between the portal circulation and the
hepatic vein.
272
Hepatic Encephalopathy and Coma
• It is called portosystemic encephalopathy (PSE)
• Is a life-threatening complication of liver
disease that occurs with profound liver failure.
Patients with this condition have no overt signs
of the illness but do have abnormalities on
neuropsychologic testing
273
Clinical Manifestations
• The earliest symptoms of hepatic
encephalopathy include minor mental changes
and motor disturbances.
• The patient appears slightly confused and
unkempt and has alterations in mood and sleep
patterns.
274
Cont’d…….
• The patient tends to sleep during the day and
has restlessness and insomnia at night.
• As hepatic encephalopathy progresses, the
patient may become difficult to awaken and
completely disoriented with respect to time
and place.
• With further progression, the patient lapses
into frank coma and may have seizures.
• Asterixis (flapping tremor of the hands) may
be seen in stage II encephalopathy 275
HEPATIC CIRRHOSIS
• Cirrhosis is a chronic disease characterized by
replacement of normal liver tissue with
diffuse fibrosis that disrupts the structure and
function of the liver.
276
• There are three types of cirrhosis or scarring of the
liver:
Alcoholic cirrhosis, in which the scar tissue
characteristically surrounds the portal areas. This is
most frequently caused by chronic alcoholism and is
the most common type of cirrhosis.
Postnecrotic cirrhosis, in which there are broad bands of
scar tissue. This is a late result of a previous bout of
acute viral hepatitis.
Biliary cirrhosis, in which scarring occurs in the liver
around the bile ducts. This type of cirrhosis usually
results from chronic biliary obstruction and infection
(cholangitis); it is much less common than the other
two types.
277
• The portion of the liver chiefly involved in
cirrhosis consists of the portal and the
periportal spaces, where the bile canaliculi of
each lobule communicate to form the liver
bile ducts. These areas become the sites of
inflammation, and the bile ducts become
occluded with inspissated (thickened) bile and
pus.
278
• The liver attempts to form new bile channels;
hence, there is an overgrowth of tissue made
up largely of disconnected, newly formed bile
ducts and surrounded by scar tissue.
279
Clinical Manifestations
• Signs and symptoms of cirrhosis increase in
severity as the disease progresses.
• Their severity is used to categorize the
disorder as compensated or decompensated
cirrhosis
280
• Compensated cirrhosis, with its less severe,
often vague symptoms, may be discovered
secondarily at a routine physical examination
• The hallmarks of decompensated cirrhosis
result from failure of the liver to synthesize
proteins, clotting factors, and other
substances and manifestations of portal
hypertension
281
282
• Liver Enlargement
• Early in the course of cirrhosis, the liver tends to be large,
• and the cells are loaded with fat. The liver is firm and has a
• sharp edge that is noticeable on palpation. Abdominal pain
• may be present because of recent, rapid enlargement of the
• liver, which produces tension on the fibrous covering of the
• liver (Glisson’s capsule). Later in the disease, the liver
decreases
• in size as scar tissue contracts the liver tissue. The
• liver edge, if palpable, is nodular.
283
• Portal Obstruction and Ascites
• Portal obstruction and ascites, late
manifestations of cirrhosis,
• are caused partly by chronic failure of liver
function and
• partly by obstruction of the portal circulation.
284
• Infection and Peritonitis
• Bacterial peritonitis may develop in patients with cirrhosis
• and ascites in the absence of an intra-abdominal source of
• infection or an abscess. This condition is referred to as
• spontaneous bacterial peritonitis (SBP). Bacteremia due to
• translocation of intestinal flora is believed to be the most
• likely route of infection.
285
• Gastrointestinal Varices
• The obstruction to blood flow through the
liver caused by
• fibrotic changes also results in the formation
of collateral
• blood vessels in the GI system and shunting of
blood from
• the portal vessels into blood vessels with
lower pressures
286
• Edema
• Another late symptom of cirrhosis is edema,
which is attributed
• to chronic liver failure. A reduced plasma
albumin concentration
• predisposes the patient to the formation of
• edema.
287
• Vitamin Deficiency and Anemia
• Because of inadequate formation, use, and
storage of certain vitamins (notably vitamins
A, C, and K), signs of deficiency are common,
particularly hemorrhagic phenomena
associated with vitamin K deficiency.
288
• Mental Deterioration
• Additional clinical manifestations include
deterioration of
• mental and cognitive function with impending
hepatic encephalopathy
• and hepatic coma, as previously described
289
Management
• Antacids or histamine-2 (H2) antagonists are
prescribed to decrease gastric distress and
minimize the possibility of GI bleeding.
• Vitamins and nutritional supplements
promote healing of damaged liver cells and
improve the patient’s general nutritional
status.
• Potassium-sparing diuretics such as spironolactone or triamterene
(Dyrenium) may be indicated to decrease ascites, if present; these
diuretics are preferredbecause they minimize the fluid and electrolyte
changescommonly seen with other agents
290
Nursing Management
• Promoting Rest
• Reducing Risk of Injury
• Improving Nutritional Status
• Providing Skin Care
• Monitoring and Managing Potential Complications
 Fluid Volume Excess
 Hepatic Encephalopathy
 Bleeding and Hemorrhage
• The patient is at increased risk for bleeding and hemorrhage because of
decreased production of prothrombin and decreased ability of the
diseased liver to synthesize the necessary substances for blood
coagulation.
291
DISORDERS OF THE GALLBLADDER
• Gallbladder disease with gallstones is the
most common disorder of the biliary system.
• Although not all occurrences of gallbladder
inflammation (cholecystitis) are related to
gallstones (cholelithiasis), more than 90% of
patients with acute cholecystitis have
gallstones.
292
293
Cholecystitis
• Cholecystitis, acute inflammation of the
gallbladder, causes pain, tenderness, and
rigidity of the upper right abdomen that may
radiate to the midsternal area or right
shoulder and is associated with nausea,
vomiting, and the usual signs of an acute
inflammation.
• An empyema of the gallbladder develops if
the gallbladder becomes filled with purulent
fluid (pus). 294
Cont….
• In calculous cholecystitis, a gallbladder stone
obstructs bile outflow.
• Bile remaining in the gallbladder initiates a chemical
reaction; autolysis and edema occur; and the blood
vessels in the gallbladder are compressed,
compromising its vascular supply.
• Gangrene of the gallbladder with perforation may
result.
• Bacteria play a minor role in acute cholecystitis;
however, secondary infection of bile occurs in
approximately 50% of cases. 295
• The organisms involved
• are generally enteric (normally live in the GI
tract) and include
• Escherichia coli, Klebsiella species, and
Streptococcus.
• Bacterial contamination is not believed to
stimulate the actual
• onset of acute cholecystitis (
296
297
Cholelithiasis
• Calculi, or gallstones, usually form in the
gallbladder from the solid constituents of bile;
they vary greatly in size, shape, and
composition (Fig. 40-2).
• They are uncommon in children and young
adults but become more prevalent with
increasing age, affecting 30% to 40% of people
by the age of 80 years.
298
Pathophysiology
• There are two major types of gallstones: those composed
• predominantly of pigment and those composed primarily of
• cholesterol. Pigment stones probably form when
unconjugated
• pigments in the bile precipitate to form stones; these
• stones account for about 10% to 25% of cases in the United
• States (Feldman, et al., 2006). The risk of developing such
• stones is increased in patients with cirrhosis, hemolysis, and
• infections of the biliary tract. Pigment stones cannot be
dissolved
• and must be removed surgically.
299
• Cholesterol stones account for most of the remaining
• 75% of cases of gallbladder disease in the United States.
• Cholesterol, a normal constituent of bile, is insoluble in water.
• Its solubility depends on bile acids and lecithin
(phospholipids)
• in bile. In gallstone-prone patients, there is decreased
• bile acid synthesis and increased cholesterol
• synthesis in the liver, resulting in bile supersaturated with
• cholesterol, which precipitates out of the bile to form
• stones.
300
• Two to three times more women than men develop
cholesterol
• stones and gallbladder disease; affected women are
• usually older than 40 years of age, multiparous, and
obese.
• Stone formation is more frequent in people who use
oral
• contraceptives, estrogens, or clofibrate; these
medications
• are known to increase biliary cholesterol saturation.
301
302
Clinical Manifestations
• Gallstones may be silent, producing no pain
and only mild
• GI symptoms. Such stones may be detected
incidentally
• during surgery or evaluation for unrelated
problems.
303
• The patient with gallbladder disease resulting from gallstones
• may develop two types of symptoms: those due to
• disease of the gallbladder itself and those due to obstruction
• of the bile passages by a gallstone. The symptoms may be
• acute or chronic. Epigastric distress, such as fullness,
abdominal
• distention, and vague pain in the right upper quadrant
• of the abdomen, may occur. This distress may follow a
• meal rich in fried or fatty foods.
304
• Pain and Biliary Colic
• Jaundice
• Changes in Urine and Stool Color
• Vitamin Deficiency
305
Assessment and Diagnostic Findings
• Abdominal X-Ray
• Ultrasonography
• Cholecystography
306
Medical Management
• The major objectives of medical therapy are to
reduce the
• incidence of acute episodes of gallbladder pain and
cholecystitis
• by supportive and dietary management and, if
possible,
• to remove the cause of cholecystitis by
pharmacologic
• therapy, endoscopic procedures, or surgical
intervention.
307
• Although nonsurgical approaches eliminate risks associated
• with surgery, these approaches are associated with persistent
• symptoms or recurrent stone formation. Most of the
nonsurgical
• approaches, including lithotripsy and dissolution of
• gallstones, provide only temporary solutions to gallstone
• problems and are infrequently used in the United States. In
• some instances, other treatment approaches may be
indicated;
• these are described later.
308
• Removal of the gallbladder (cholecystectomy) through
• traditional surgical approaches was the standard treatment
• for more than 100 years. It has largely been replaced by
laparoscopic
• cholecystectomy (removal of the gallbladder
• through a small incision through the umbilicus). As a result,
• surgical risks have decreased, along with the length of
• hospital stay and the long recovery period required after
• standard surgical cholecystectomy. In relatively rare instances,
• a standard surgical procedure may be necessary.
309
• Nutritional and Supportive Therapy
• Approximately 80% of the patients with acute gallbladder
• inflammation achieve remission with rest, IV fluids,
nasogastric
• suction, analgesia, and antibiotic agents. Unless the
• patient’s condition deteriorates, surgical intervention is
delayed
• just until the acute symptoms subside (usually within
• a few days). At this time, the patient should undergo a
laparoscopic
• cholecystectomy
310
• Pharmacologic Therapy
• Ursodeoxycholic acid (UDCA [URSO, Actigall])
and chenodeoxycholic
• acid (chenodiol or CDCA [Chenix]) have
• been used to dissolve small, radiolucent
gallstones composed
• primarily of cholesterol.
311
312

More Related Content

Similar to GIT, GUT, muskulo.ppt. MSN (4).ppt

CM3 - CU14 ASSESSMENT OF ABDOMEN.pdf
CM3 - CU14 ASSESSMENT OF ABDOMEN.pdfCM3 - CU14 ASSESSMENT OF ABDOMEN.pdf
CM3 - CU14 ASSESSMENT OF ABDOMEN.pdfZyraPascual1
 
Presentation tation of cancer related to g i tract
Presentation tation of cancer related to g i tractPresentation tation of cancer related to g i tract
Presentation tation of cancer related to g i tractgoverment nursing college.
 
Small intestine
Small intestineSmall intestine
Small intestineFidelSimba
 
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptxrenecorpuz1
 
Presentation1 liver ultrasound
Presentation1 liver ultrasoundPresentation1 liver ultrasound
Presentation1 liver ultrasoundAbdallah Bashe
 
Biliary Tract Diseases.ppt
Biliary Tract Diseases.pptBiliary Tract Diseases.ppt
Biliary Tract Diseases.pptSufaMengiste
 
Rafdhi - Colon, Rectum, & Anus.pptx
Rafdhi - Colon, Rectum, & Anus.pptxRafdhi - Colon, Rectum, & Anus.pptx
Rafdhi - Colon, Rectum, & Anus.pptxariel740821
 
Dr. kawa bilateral
Dr. kawa bilateralDr. kawa bilateral
Dr. kawa bilateralRzgar Tayeb
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer diseaseHIRENGEHLOTH
 
Pancreatic Pseudocyst.pptx
Pancreatic Pseudocyst.pptxPancreatic Pseudocyst.pptx
Pancreatic Pseudocyst.pptxRachaelMoraa
 
tuberculosis of the abdominal
tuberculosis of the abdominal tuberculosis of the abdominal
tuberculosis of the abdominal paras suthar
 
tuberculosis of the abdominal
tuberculosis of the abdominal tuberculosis of the abdominal
tuberculosis of the abdominal paras suthar
 
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV  Gasitrointesitinal disorders pharmacotherapy.pptxPart IV  Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV Gasitrointesitinal disorders pharmacotherapy.pptxAbdiIsaq1
 

Similar to GIT, GUT, muskulo.ppt. MSN (4).ppt (20)

CM3 - CU14 ASSESSMENT OF ABDOMEN.pdf
CM3 - CU14 ASSESSMENT OF ABDOMEN.pdfCM3 - CU14 ASSESSMENT OF ABDOMEN.pdf
CM3 - CU14 ASSESSMENT OF ABDOMEN.pdf
 
Constipation
ConstipationConstipation
Constipation
 
FINALS.pptx
FINALS.pptxFINALS.pptx
FINALS.pptx
 
Presentation tation of cancer related to g i tract
Presentation tation of cancer related to g i tractPresentation tation of cancer related to g i tract
Presentation tation of cancer related to g i tract
 
CROHN'S DISEASE
CROHN'S DISEASE CROHN'S DISEASE
CROHN'S DISEASE
 
Final year students
Final year studentsFinal year students
Final year students
 
Small intestine
Small intestineSmall intestine
Small intestine
 
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx
3. 13 Mar 20 Acid Peptic Disease2 dt 13 mar 2020.pptx
 
Presentation1 liver ultrasound
Presentation1 liver ultrasoundPresentation1 liver ultrasound
Presentation1 liver ultrasound
 
Biliary Tract Diseases.ppt
Biliary Tract Diseases.pptBiliary Tract Diseases.ppt
Biliary Tract Diseases.ppt
 
Rafdhi - Colon, Rectum, & Anus.pptx
Rafdhi - Colon, Rectum, & Anus.pptxRafdhi - Colon, Rectum, & Anus.pptx
Rafdhi - Colon, Rectum, & Anus.pptx
 
Dr. kawa bilateral
Dr. kawa bilateralDr. kawa bilateral
Dr. kawa bilateral
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Cystic fibrosis
Cystic fibrosis Cystic fibrosis
Cystic fibrosis
 
Pancreatic Pseudocyst.pptx
Pancreatic Pseudocyst.pptxPancreatic Pseudocyst.pptx
Pancreatic Pseudocyst.pptx
 
tuberculosis of the abdominal
tuberculosis of the abdominal tuberculosis of the abdominal
tuberculosis of the abdominal
 
tuberculosis of the abdominal
tuberculosis of the abdominal tuberculosis of the abdominal
tuberculosis of the abdominal
 
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV  Gasitrointesitinal disorders pharmacotherapy.pptxPart IV  Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
 
222222.pptx
222222.pptx222222.pptx
222222.pptx
 

More from AbdiWakjira2

Nursing management of patient with Respiratory DO.pptx
Nursing management of patient with  Respiratory DO.pptxNursing management of patient with  Respiratory DO.pptx
Nursing management of patient with Respiratory DO.pptxAbdiWakjira2
 
Nursing care of patient with EMPYEMA (1).pptx
Nursing care of patient with EMPYEMA (1).pptxNursing care of patient with EMPYEMA (1).pptx
Nursing care of patient with EMPYEMA (1).pptxAbdiWakjira2
 
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDER
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDERMANAGEMENT OF PATIENT WITH ENDOCRINE DISORDER
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDERAbdiWakjira2
 
Health promotion & Disease prevention for post basic nursing students part 1...
Health promotion & Disease prevention for post basic nursing students  part 1...Health promotion & Disease prevention for post basic nursing students  part 1...
Health promotion & Disease prevention for post basic nursing students part 1...AbdiWakjira2
 
Assessment &Nursing management of patient with INTEGUMENTARY DO EDIT.pptx
Assessment &Nursing management of patient with  INTEGUMENTARY DO EDIT.pptxAssessment &Nursing management of patient with  INTEGUMENTARY DO EDIT.pptx
Assessment &Nursing management of patient with INTEGUMENTARY DO EDIT.pptxAbdiWakjira2
 
Nursing care for patient with CHICKEN POX [Autosaved].pptx
Nursing care for patient with CHICKEN POX [Autosaved].pptxNursing care for patient with CHICKEN POX [Autosaved].pptx
Nursing care for patient with CHICKEN POX [Autosaved].pptxAbdiWakjira2
 
Assisting with Cast application and removal.pptx
Assisting with Cast application and removal.pptxAssisting with Cast application and removal.pptx
Assisting with Cast application and removal.pptxAbdiWakjira2
 
Lower respiratory tract disorder ATELECTASIS
Lower respiratory tract  disorder  ATELECTASISLower respiratory tract  disorder  ATELECTASIS
Lower respiratory tract disorder ATELECTASISAbdiWakjira2
 
Nursing assessment.pptx
Nursing assessment.pptxNursing assessment.pptx
Nursing assessment.pptxAbdiWakjira2
 
Common URTI diseases.pptx
Common URTI diseases.pptxCommon URTI diseases.pptx
Common URTI diseases.pptxAbdiWakjira2
 
Assignment on Cancer care.pptx
Assignment on Cancer care.pptxAssignment on Cancer care.pptx
Assignment on Cancer care.pptxAbdiWakjira2
 
Respiratory Disorders ppt.pptx
Respiratory Disorders ppt.pptxRespiratory Disorders ppt.pptx
Respiratory Disorders ppt.pptxAbdiWakjira2
 
Nursing Management of patient with Respiratory system (1).ppt
Nursing Management of patient with Respiratory system (1).pptNursing Management of patient with Respiratory system (1).ppt
Nursing Management of patient with Respiratory system (1).pptAbdiWakjira2
 
10.GIT physiology (1).ppt
10.GIT physiology (1).ppt10.GIT physiology (1).ppt
10.GIT physiology (1).pptAbdiWakjira2
 
abdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxabdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxAbdiWakjira2
 
abdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxabdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxAbdiWakjira2
 

More from AbdiWakjira2 (20)

Nursing management of patient with Respiratory DO.pptx
Nursing management of patient with  Respiratory DO.pptxNursing management of patient with  Respiratory DO.pptx
Nursing management of patient with Respiratory DO.pptx
 
Nursing care of patient with EMPYEMA (1).pptx
Nursing care of patient with EMPYEMA (1).pptxNursing care of patient with EMPYEMA (1).pptx
Nursing care of patient with EMPYEMA (1).pptx
 
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDER
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDERMANAGEMENT OF PATIENT WITH ENDOCRINE DISORDER
MANAGEMENT OF PATIENT WITH ENDOCRINE DISORDER
 
Health promotion & Disease prevention for post basic nursing students part 1...
Health promotion & Disease prevention for post basic nursing students  part 1...Health promotion & Disease prevention for post basic nursing students  part 1...
Health promotion & Disease prevention for post basic nursing students part 1...
 
Assessment &Nursing management of patient with INTEGUMENTARY DO EDIT.pptx
Assessment &Nursing management of patient with  INTEGUMENTARY DO EDIT.pptxAssessment &Nursing management of patient with  INTEGUMENTARY DO EDIT.pptx
Assessment &Nursing management of patient with INTEGUMENTARY DO EDIT.pptx
 
Nursing care for patient with CHICKEN POX [Autosaved].pptx
Nursing care for patient with CHICKEN POX [Autosaved].pptxNursing care for patient with CHICKEN POX [Autosaved].pptx
Nursing care for patient with CHICKEN POX [Autosaved].pptx
 
Assisting with Cast application and removal.pptx
Assisting with Cast application and removal.pptxAssisting with Cast application and removal.pptx
Assisting with Cast application and removal.pptx
 
Lower respiratory tract disorder ATELECTASIS
Lower respiratory tract  disorder  ATELECTASISLower respiratory tract  disorder  ATELECTASIS
Lower respiratory tract disorder ATELECTASIS
 
Epiglottitis.pptx
Epiglottitis.pptxEpiglottitis.pptx
Epiglottitis.pptx
 
Nursing assessment.pptx
Nursing assessment.pptxNursing assessment.pptx
Nursing assessment.pptx
 
Common URTI diseases.pptx
Common URTI diseases.pptxCommon URTI diseases.pptx
Common URTI diseases.pptx
 
CHICKEN POX.pptx
CHICKEN POX.pptxCHICKEN POX.pptx
CHICKEN POX.pptx
 
Assignment on Cancer care.pptx
Assignment on Cancer care.pptxAssignment on Cancer care.pptx
Assignment on Cancer care.pptx
 
Respiratory Disorders ppt.pptx
Respiratory Disorders ppt.pptxRespiratory Disorders ppt.pptx
Respiratory Disorders ppt.pptx
 
D3-UNICEF.ppt
D3-UNICEF.pptD3-UNICEF.ppt
D3-UNICEF.ppt
 
Oncology 2.pptx
Oncology 2.pptxOncology 2.pptx
Oncology 2.pptx
 
Nursing Management of patient with Respiratory system (1).ppt
Nursing Management of patient with Respiratory system (1).pptNursing Management of patient with Respiratory system (1).ppt
Nursing Management of patient with Respiratory system (1).ppt
 
10.GIT physiology (1).ppt
10.GIT physiology (1).ppt10.GIT physiology (1).ppt
10.GIT physiology (1).ppt
 
abdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxabdominal visceraWU(0).pptx
abdominal visceraWU(0).pptx
 
abdominal visceraWU(0).pptx
abdominal visceraWU(0).pptxabdominal visceraWU(0).pptx
abdominal visceraWU(0).pptx
 

Recently uploaded

psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIShubhangi Sonawane
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 

Recently uploaded (20)

psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 

GIT, GUT, muskulo.ppt. MSN (4).ppt

  • 1. . Medical surgical nursing By Dawit Tesfaye(Bsc, MSC)
  • 2. General objective • After completion of this course, the student will be able to assess, diagnose and manage patients with medical surgical disorders related to GIT , GUT and musculoskeletal disorders and / or refer those requiring higher level of management.
  • 3. Contents • Unit 1: Gastrointestinal tract (GIT) disorders • Unit 2: Genito urinary tract (GUT) disorders • Unit 3: Musculoskeletal system disorders
  • 4. . References: 1) Donna D. IGNATAVICIUS. A Nursing Process approach Medical surgical 2) Medical surgical Brunner 11th Edition 3) Lackman and Sorensson medical surgical nursing 4) Sharon medical surgical Nursing 5) Harrison’s principle of internal Medicine 16th edition
  • 5. Management of patients with Gastro intestinal tract (GIT) disorders. 5`
  • 6. Anatomy and physiology • The GIT tract is pathway (23-to-26 feet or 7-8 meter in length) that extends from the mouth through the esophagus, stomach and intestines to the anus. • It also includes organs that lie out side the digestive tract i.e. pancreas, liver and gall bladder. 6
  • 7. Mouth and related structures' • Digestion normally begins in the mouth, Mouth and related structures includes • Mucus membranes of the mouth • Teeth • Gums • Lips • Soft and hard plates 7
  • 8. Fig. Mouth and related structures 8
  • 9. Cont---  Esophagus: is located in the mediastinum in the thoracic cavity anterior to the spine and posterior to the trachea and heart. • Length: 23-25 cm (10 inch). • At the upper end of the esophagus there is a sphincter i.e. upper esophageal sphincter. 9
  • 11. Cont--- Stomach • Location: is situated in the upper portion of the abdomen to the left of the midline. • Capacity: about 1500ml. 11
  • 12. Cont---- • The stomach can be divided in to four anatomic regions The cardia (entrance) Funds Body and pylorus (outlet) 12
  • 13. Fig. anatomical regions of the stomach 13
  • 14. Cont--- • The inlet of the stomach is called the esophagogastric junction. • In the inlet there is lower esophageal sphincter (or cardiac sphincter). • In the out let: pyloric sphincter. 14
  • 15. Cont--- Small intestine : is the longest segment of the GI tract accounting for about 2/3 of the total length • Length: 5-6meters (16-19 feet) • It is divided in to three anatomic parts • The upper part, called the duodenum, • The middle part called the jejunum and • The lower part called the ileum. 15
  • 16. Cont--- The large intestine: consists of – ascending colon – transverse colon – Descending colon 16
  • 17. Cont--- Cecum: is found in junction between the small and large intestine. • Is located in the right lower portion of the abdomen. • The ileocecal value is located at this junction. • The vermiform appendix is located near this junction. 17
  • 18. Cont--- The terminal portion of the large intestine consists of two parts • The sigmoid colon and the rectum • The rectum is continuous with the anus. 18
  • 20. Function of the Digestive system – To breakdown food particles in to the molecular form for digestion – To absorb the small molecules in to the blood stream, produced by digestion – To eliminate undigested and unabsorbed food stuffs and other waste products from the body. i.e. secretion, digestion, absorption, motility and elimination. 20
  • 21. Diagnostic test for common GIT problems I) Radiography: • Is a simple x-ray without contrast agents. • It shows obstruction or paralysis of the digestive tract or abdominal air patterns in the abdominal cavity . • Also shows enlargements of organs like liver. 21
  • 22. Cont--- II) Barium studies • Entire GI tract can be out lined using a contrast agent such as barium sulfate.  Barium swallow: ingested orally  Barium enema: instilled rectally 22
  • 23. Cont--- III) Endoscopic procedures • Examination of internal structures using a viewing tube /endoscope. • Many endoscopes have small scissors to remove tissue sample and electric probe to destroy abnormal tissue. 23
  • 24. Cont--- A) Esophago gastro duodenoscopy (EGDS) • Allows for direct visualization of esophageal, gastric, and duodenal mucosa through a lighted endoscopy. • Used for both diagnosis and treatment purpose. • Pt NPO b/r and after the procedure. • Local anesthetic sprayed is indicated. • Position : left lateral. 24
  • 26. Cont--- B) Laparoscopy • Insert through the skin in the abdominal wall under spinal or general anesthesia. • Used to screen for tumor or other abnormalities, to obtain sample, and to examine any organ in the abdominal cavity 26
  • 27. Cont--- C) Proctoscopy and sigmoidoscopy • used to inspect/examine the rectum and sigmoid colon respectively for the evidence of ulceration, tumors, polyps, and other abnormalities D) Colonoscopy • Examine the colon to the cecum 27
  • 30. Cont--- IV) Gastric analysis • Small tube into the stomach to obtain a fluid sample. • Stomach contents are aspirated by suction into the syringe • May be performed to diagnose gastric CA 30
  • 31. Cont--- V) Stool examination • Inspected for color, and consistency. • If blood is lost large amount in the upper GIT blood produce a tary black color/ Melena. • If blood entering the lower portion of GIT (passing rapidly through) it will appear bright or dark red. 31
  • 32. Cont--- • If there is streaking of blood on the surface of the stool or if blood is noted on the toilet i.e. lower rectal or anal bleeding is suspected. • N.B. fecal occult blood test (FOBT) is a common stool test to detect for CA(GI bleeding associated with colorectal cancer) 32
  • 33. Assessment Health history and clinical manifestations • The nurse begins by taking a complete history, focusing on symptoms common to GI dysfunction 33
  • 34. Cont--- symptoms include: - Pain - can be major symptoms - Notify - the character - location - Duration - Frequency - Time of the pain - Underline cause 34
  • 36. Cont--- • Indigestion - due to disturbed nerves control of the stomach • Intestinal “Gas" (Belching and flatulence) • Accumulation of gas in GIT may result belching • Vomiting • Hematemesis - vomiting of blood : bright red or coffee ground appearance 36
  • 37. Cont--- • Diarrhea - abnormal in stool liquidity • Constipation - difficult defecation.  Physical assessment • The Physical examination includes assessment of the mouth, abdomen and rectum. • Inspection ---- auscultation --- percussion ---- palpation. 37
  • 39. Problems of oral related structures • Adequate nutrition is related to good dental health and the general condition of the mouth, because digestion normally begins in the mouth. • Changes in the oral cavity may influence the type and amount of food ingested as well as the degree to which food particles are properly mixed with salivary enzymes. 39
  • 41. A) Oral candidiasis /Trush • Cheesy white plaque that looks like milk curds w/n rubbed off it leaves erythematous and often bleeding base. • Is caused by fungus. • Candida albicans is the most common agents of candidiasis. • Is the common form of candidiasis 41
  • 42. Predisposing factors Poor oral hygiene Chronic illness like DM, HIV Immunosuppressive therapy e.g. radiation steroid therapy Long term antibiotic therapy. 42
  • 45. Cont---  S/ Sx –Cheesy white plaque –Erythematous /reddened/and often bleeding gums.  Mgt –Antifungal medications Nystatin Clotrimazole or ketokonazole 45
  • 46. Complication • Esophageal candidiasis • Oral cancer • Systemic candidiasis (life threatening) 46
  • 47. B) Leukoplakia  Chronic inflammation with thick patches on mucous membrane.  Slowly developing changes in the oral mucosa membrane that are characterized by thickened white, firmly attached patches. 47
  • 48. Cont--- • White patches usually on the tongue, gums, and inside of checks. • 90% of leukoplakia lesions are benign, however, up to 7% of lesions becomes malignant after many years. • Lesions on the lips and tongue are more likely to progress to malignancy 48
  • 51. Causes • Chronic irritation of the mouth (e.g. poorly fitting dentures, broken or poorly repaired teeth) • Smoking, infected teeth. • Very spicy foods • Immunosuppressant e.g. HIV • N.B. it can confused with oral Candidal infection however, leukoplakia can’t removed by scraping. 51
  • 52. Cont--- • Hairy" leukoplakia of the mouth is an unusual form of leukoplakia that is seen mostly in HIV- positive people. • It may be one of the first signs of HIV infection. 52
  • 54. Symptoms • The most common symptoms of hairy leukoplakia are painless, fuzzy /hairy white patches on the side of the tongue. • The skin lesions tend to have the following characteristics: • Location – Usually on the tongue – May be on the inside of the cheeks 54
  • 55. Cont--- • Color – Usually white or gray – May be red (called erythroplakia, a condition that can lead to cancer) • Texture – Thick – Slightly raised – Hardened surface 55
  • 56. Management • Removing the source of irritation is important and may cause the lesion to disappear. • Treat dental causes such as rough teeth, irregular denture surface, etc • Stop smoking and do not drink alcohol. • Some times surgery may require to remove the lesion. 56
  • 57. Prognosis • Lesions often clear up in a few weeks or months after the source of irritation is removed. 57
  • 58. C) Stomatitis • Is also called canker sore • Shallow ulcer with a white center and red border • The sore usually forms on the soft, loose tissues particularly on the inside of the lips or cheek, tongue, soft palate and sometimes in the throat. • It is very common (affecting 20% of the general population to some degree) • Episode occurs 3-6 times per year 58
  • 59. Cont--- • It can be:  small or large canker sore 59
  • 60. Possible causes  Vitamin deficiency (B- complex, folic acids, Zink, iron)  infection (bacterial, viral or fungus)  systemic diseases (HIV, DM, leukemia)  irritants ( tobacco, and alcohol) Chemotherapy or radiation therapy. allergies, acidic foods it is also associated with emotional or mental stress, fatigue, or hormonal factors and genetic predisposition 60
  • 61. Sign and symptoms • No detectable systemic symptoms of or signs out side the mouth • pain lasts 4-10 days • Fever and dry mouth • Shallow ulcer with or gray center and red border. • It begins with burning, itiching or tingling sensation and slight swelling • Tongue may be dry, cracked, contain masses or exudates. • Sensitivity to hot and spicy foods. • Oral bleeding 61
  • 62. Mgt • Control or remove causes – Improve diet – Rx treatment of underlying infections with Abs. • Good oral hygiene  Medications • Analgesics for pain, • Topical/systemic steroids 62
  • 63. Cont--- Antimicrobials (to treat as well as to prevent secondary infection) • Abs E .g. TTC syrup 250/10ml QID for 10 days. • Antiviral:  IV acyclovir (infused at constant rate over a 1hr period every 8hrs for 7days • Antifungal • Rest: to promote tissue repair 63
  • 64. Reading assignment Disorders of teeth gums & salivary gland –Gingivitis –Dental plaque and caries/cavities –Periapical abscess –Parotits –Oral cancer 64
  • 65. Esophageal disorders There are many pathologic conditions of the esophagus, including: • Esophagitis • Motility disorders • Hiatal hernias, and • Diverticula, 65
  • 66. A) Esophagitis • Is an acute or chronic inflammation of the esophagus. • It also called gastro esophageal Reflux disease (GERD). 66
  • 67. Causes • Gastro esophageal reflux – Inappropriate relaxation of LES. – Delayed gastric emptying – Medication that reduces strength of LES (like OCP, nitrates, sedatives, B- blockers, calcium channel blockers and anticholinergics) • Trauma – Swallowing of foreign bodies – Prolonged Naso - gastric intubation – Repeated vomiting • Infection • Chemicals: acids, alkalis 67
  • 68. C/M • Dyspepsia/indigestion • Heart burn • A sensation of acidic or bitter regurgitation associated with nausea • Bleeding (acute or chronic  Dysphagia or odynophagia (pain on swallowing)  Pain on drinking/alcohol, hot or cold fluid  Worsen w/n the client bends over, strain, or in recumbent position. 68
  • 69. Diagnosis • Using c/m • Esophagoscopy 69
  • 70. Management • Depends on the cause of esophagitis 1) life style changes – The patient is instructed to eat slowly and chew foods thoroughly (to avoid belching ) – avoid caffeine, beer /alcohol and smoking, – Avoid acidic foods e.g. orange juice, tomatoes etc. – Raising the head of the bed /15-20cm 70
  • 71. Cont--- - Remain upright 1-2hrs after meal - No food or drink with in 2-3hrs of bed time - Avoid lifting of heavy objects or straining and working in bent over position. - Avoid heavy meal / Eat a low-fat diet - Encourage small and frequent diet 4-6 times than large foods 3 times /day - N.B. left lateral position reduces GER! 71
  • 72. Cont--- 2) Chemotherapy • Antacids after each meal and before bed time. • Accelerate gastric emptying e.g. metoclopramide /prokinetic drugs • Anti secretory agents • Antibiotics if associated with infection 72
  • 73. 2) Achalasia • Is a motility disorder. • Is absent or ineffective peristalsis of the distal esophagus accompanied by failure of the esophageal sphincter to relax in response to swallowing. 73
  • 74. Cont--- • Narrowing of the esophagus just above the stomach results in gradually increasing dilation of the esophagus in the upper chest. • The exact cause is unknown 74
  • 76. c/m • Difficulty in swallowing ( both liquid and solid): The 1st symptom • Sensation of food sticking in the lower portion • Food is commonly regurgitated, • May have chest pain and heart burn • Halitosis (unpleasant-smelling breath) • Pain may or may not be associated with eating 76
  • 77. Diagnostic Evaluation • Radiological studies - show esophageal dilation above the narrowing at the gastro esophageal junction • Barium swallow and endoscopy may be used to diagnosis. • c/ms 77
  • 78. Management • Patient should be instructed to eat slowly and to drink fluids with meals and avoid foods that aggravate the condition. • Mild cases can be treated with Ca++ channel blockers and nitrates have been used to decrease lower esophageal pressure and improve swallowing. 78
  • 79. Cont--- • If this is unsuccessful • pneumatic (forceful) dilation: by passing a tube into the esophagus i.e. large metal stents maybe used to keep esophagus open for longer duration. • Has 75% success rate and a 3% incidence of perforation 79
  • 80. Fig. Dilation of narrowed esophagus 80
  • 81. Cont--- • Surgical separation of the, muscle fibers may be recommended /esophagomyotomy /LES incised. 81
  • 83. C) Esophageal Diverticula /pouches • Diverticulum: is an out pouching of mucosa and sub mucosa that protrudes through a weak portion of the musculature. • Esophageal diverticula: is a sacs resulting from the herniation of esophageal mucosa and sub mucosa into the surrounding tissue. 83
  • 84. Cont--- It may occur in one of the three areas of the esophagus:- • The pharyngo - esophageal or upper area of the esophagus (most common) • The mid esophageal area or • Epiphrenic or lower area of the esophagus 84
  • 87. C/M • Difficulty swallowing • Fullness in the neck (feeling that food stops before reaching in to the stomach) • Belching • Halitosis • Regurgitation of undigested foods • Diverticulum /pouch filled with food or fluid 87
  • 88. Dx • Esophago gastro dodunoscopy after barium swallow. 88
  • 89. Management • The only means of cure is surgical removal of the diverticulum /diverticullectomy • After surgery foods and fluids are withheld until x-ray is confirm no leakage at surgical site. 89
  • 90. Gastric and duodenal disorders A) Gastritis Inflammation of the gastric or stomach mucosa  it is a common GI problem. It may be acute, lasting several hours to few days, or chronic , resulting from repeated exposure to irritating agents or recurring episodes of acute gastritis. 90
  • 91. Cont--- Acute gastritis : inflammation of the gastric mucosa after exposure to local irritants. Causes: • is often caused by dietary indiscretion. • The person eats too much or too rapidly or eats food that is contaminated or too highly seasoned or is infected. 91
  • 92. Cont--- • Other cause includes – alcohol, aspirin, bile reflux, or radiation , infection (staph, strep, E. coli, salmonella. ) • More severe form of acute gastritis is caused by ingestion of strong acids or alkalis • Gastritis also may be the 1st sign of an acute systemic infection 92
  • 93. Cont---  C/M - Acute gastritis • Rapid onset of gastric pain or discomfort • Dyspepsia /heart burn • Abdominal discomfort • Headache • Nausea, anorexia • Vomiting / hematemesis • Some patients, however, are asymptomatic. 93
  • 94. Cont--- Chronic gastritis – Prolonged inflammation of the stomach may be caused by either benign or malignant ulcers of the stomach or by the bacteria helicobacter pylori. – Appears as a patchy diffuse/spread out inflammation of the mucosal lining of the stomach. 94
  • 95. Cont--- • it may also be associated with dietary factors such as hot drinks or spices, use of drugs, alcohol, smoking or reflux of intestinal contents in to the stomach. 95
  • 96. Cont--- C/ms of chronic gastritis. • Heartburn/ epigastric pain • Anorexia • Belching • Sour taste in the mouth • Vomiting and nausea • Pernicious anemia 96
  • 97. Cont--- Diagnosis • History • Hyper chlorhydria • Endoscopy • X-ray • Serologic test (H.pylori ) 97
  • 98. Management • The gastric mucosa is capable of repairing itself after a bout of gastritis • Avoid foods /drinks that cause distress coffee, tea ,chocolate, alcohol and smoking • Instruct the patient to refrain from alcohol and food until symptoms subside. • Encourage nonirritating diet • Bed rest 98
  • 99. Cont--- for Chronic gastritis • is managed by modifying the patient’s diet • promoting rest, • reducing stress and • initiating pharmacotherapy (antacids, sucralfate, and Abs) 99
  • 100. Nursing intervention • Assess and document signs and symptoms and reactions to treatments • Monitor intake and out put. • Provide the prescribed diet. • Administer medication as prescribed and monitor for side effects. • Note amount and character of emesis and diarrhea and Monitor IV fluids. • Educate patient and family concerning drug therapy, diet activities and any restrictions. 100
  • 101. B) Peptic ulcer diseases (PUD) • A peptic ulcer is an excavation (hollowed-out area) that forms in the mucosal wall of the stomach, in the pylorus (opening between stomach and duodenum) in the duodenum or in the esophagus. • It is frequently referred to as gastric, duodenal or esophageal ulcer, depending on its location or as a peptic ulcer disease.(PUD) 101
  • 103. Cont--- • Erosion of a circumscribed area of mucus membrane is occurred. • This erosion may extend as deeply as the muscle layers or through the muscle to the peritoneum • Peptic ulcers are more likely to be in the duodenum than in the stomach, 103
  • 104. Fig. Gastric and duodenal ulcer 104
  • 106. Cont--- Incidence: • Has greater frequency occurrence b/n ages of 40 and to 60 hrs • Relatively uncommon in women child bearing ages i.e. man to women ratio 3:1 • Man to women ratio after menopause 1:1 106
  • 107. Cont--- Causes: • Increase secretion of Hcl and pepsin acid or • Decrease in the normal resistance of the mucosa. • Gram-negative bacteria H. pylori 107
  • 108. Cont--- Predisposing factors • Stress (occupational stress ,and emotionally stress • Emotional tense persons/anger • Hereditary link persons with Blood group O are 35% more susceptible than others • Other predisposing factors associated with peptic ulcer include caffeine, smoking, alcohol ingestion, chronic use of NSAIDS 108
  • 109. Pathophysiology • The erosion is due to an increase in concentration or activity of acid – pepsin or due to a decrease in the normal resistance of the mucosa. • A damaged mucosa is unable to secrete enough mucus to act as a barrier against HCl acid. 109
  • 110. Cont---- • When a break in mucosal barrier; the Hcl injuries the epithelium. • Rapidly emptying of food from stomach reduces the buffering effects of food and delivers a large acid bolus to the duodenum leading to duodenal ulcer. 110
  • 111. Clinical manifestation • Symptoms ulcer may last for a few days, weeks, months may even not disappear. • Dyspepsia/ indigestion: discomfort centered around the epigastrium or upper abdomen is the most common reported symptoms 111
  • 112. Cont--- • Pain – dull, gnawing(cramp) pain, or a burning sensation in the mid epigatrium or in the back. • It is believed that pain occurs w/n there is increased acid content of the stomach and duodenum. • Sharply localized tenderness can be elicited by applying gentle pressure to the epigastrium or slightly to the right of the midline. • Some relief is obtained by applying local pressure on the epigastrum. 112
  • 113. Cont--- • Pyrosis(heart burn): some patients experience a burning sensation in the esophagus and stomach. • Vomiting : is rare in uncomplicated duodenal ulcers. • Constipation and bleeding: perforation or hemorrhage may occur with any preceding manifestations. • Abdominal distention/fullness. 113
  • 114. Comparing Duodenal and Gastric Ulcer  Duodenal Ulcer/DU Incidence • Age 30-60 • Take 80% • hyper secretion of HCL  Gastric Ulcer/GU • Usually 50 and above • 15% of cases • Normal-hypo secretion of HCL 114
  • 115. DU GU • Pain occurs after 2-3hrs of a meal • Ingestion of food relives pain • May have wt gain • Vomiting uncommon • Pain occurs ½ to 1hr after a meal ;may relived by vomiting • Ingestion doesn’t help, sometimes it may increase pain; • Weight loss may occur • Vomiting common 115
  • 116. DU GU • Hemorrhage less likely than with G.U • But if present, melena is more common than hematemesis • More likely to perforate than G.U • Malignancy : rare • Hemorrhage more likely to occur than with duodenal ulcer; • Hematemesis more common than melena • less likely to perforate • Malignancy:occasionally 116
  • 117. Diagnostic Evaluation • History and physical examination/bowel sound may be absent • C/ms: Pain relived by ingesting food or antacids – suggestive of duodenal ulcer. • Barium study of the upper GI tract may show an ulcer - X-ray 117
  • 118. Diagnosis Cont--- • Endoscopy: is the preferred diagnostic procedure to detect those lesions not evident in x ray studies b/c of the size and location of lesions. • Stool- for occult blood • Gastric secretion studies • Serologic test for antibodies of H.pylori Ag. 118
  • 119. Management of PUD A) Nondrug management • Stress reduction and rest • Smoking cessation Dietary modification: avoid foods that increase secretion of acid e.g. coffee, alcohol, cola, cram, milk, 119
  • 120. Cont--- • Small and frequent foods • Food it self acts as an antacid by neutralizing gastric acid for 30-60 minutes then an increased gastric secretion follows. • Follow up care 120
  • 121. Cont--- B) Drug mgt I) Antacids • Magnesium hydroxide and or Aluminum hydroxide 50-80 MEq 1hr and 3 hr after meal and at bed time. 121
  • 122. Cont--- II) H2 Receptors antagonist • Cimetidine : 300mg PO Qid for 4-6 week (400mg BID and 800 mg once) • Ranitidine : 150 mg PO BID for 4-6 week (300mg PO at bed time) • Famotidine : 40 mg po once a day for 4-6 week • Nizatidine : 150 mg PO BID or 300mg at bed time. 122
  • 123. Cont--- III) Antisecrotary agents • Omeprazole 20mg PO BID or 40mg at bed time • Lansoprazole 15 or 30 mg PO at bed time. • Panto prazole 40mg PO IV daily • Esomeprazole 20mg or 40 mg PO daily. IV) Mucosal barrier fortifiers • Sucralfate 1gm PO QID or 2gm twice daily. 123
  • 124. Cont--- . V) Antimicrobes • Clarithromycin 500 mg PO TID • Amoxicillin 1 gm PO BID • TTC 500 mg PO QID • Metrindazole 250 mg PO TID at bed time. 124
  • 125. Cont--- PUD associated with H. pylori • First line: Amoxicillin 1gm PO BID + clarithromycin 500 mg PO BID + omeprazole 20mg PO BID or 40mg once daily. • Alternative: amoxicillin + metrindazole 500mg PO BID + omeprazole 125
  • 126. Cont--- C) Surgical management • Surgical intervention for peptic ulcers is less common • It usually recommended for patient with intractable ulcers, life threatening hemorrhage, perforation, obstruction 126
  • 127. Cont--- It includes: A) Vagotomy: Severing of the vagus nerve. Decreases gastric acid by diminishing cholinergic stimulation to the parietal cells, making them less responsive to gastrin.  reduce gastric acid secretion 127
  • 129. Cont--- B) Billroth I : antrectomy with anastmosis to the duodenum / gastro- duodenostomy • Removal of the lower portion of the antrum of the stomach (which contains the cells that secrete gastrin) as well as a small portion of the duodenum and pylorus. • The remaining segment is anastomosed to the duodenum (Billroth I) 129
  • 131. Cont--- c) Billroth II: antrectomy with anastmosis to the jejunum /gastro- jejunostomy. • Removal of distal third of stomach; anastomosis with jejunum. • Removes gastrin -producing cells in the antrum and part of the parietal cells 131
  • 133. Cont--- • Potential complications – Hemorrhage – Perforation – Pyloric obstruction (it occurs when the area distal to the pyloric sphincter becomes scarred and stenosed from spasm or edema) – Intractable ulcers (hard to control) 133
  • 134. C) Gastric Cancer • Mostly occurs in people over age of 40 and occasionally in younger people. • Most stomach cancers occur in the lesser curvature , pylorus or antrum of the stomach and are adenocarcinomas • The tumor infiltrates the surrounding mucosa, penetrating the wall of the stomach & adjacent organs and structures 134
  • 135. Cont--- • The liver, pancreas, esophagus and duodenum are often affected at the time of diagnosis. • Diet appears to be a significant factor. i.e. a diet high in smoked foods and low in fruits & vegetables may increase the risk of gastric cancer. • Other factors related to the incidence of gastric Ca include chronic inflammation of the stomach, pernicious anemia, achlohydria, gastric ulcers, H. pylori infection and genetics. 135
  • 137. Cont--- C/M • In the early stage of gastric Ca symptoms may be absent.  Symptoms of progressive disease may include: • anorexia( lack of appetite), dyspepsia, (indigestion), wgt loss, abdominal pain, constipation, anemia & N/V. 137
  • 138. Cont--- Diagnostic Evaluation • P/E is usually not help full, as most gastric tumors are not palpable • X-ray with barium swallows. • Endoscope for Biopsy and cytological study • Computed tomography (CT) scan 138
  • 139. Cont--- Management • There is no successful Rx of gastric carcinoma except removal of the tumor. • If the tumor can be removed while it is still localized to the stomach, the patient can be cured. • If the tumor has spread beyond the area –cure cannot be effective 139
  • 140. Cont--- Surgical mgt • Radical subtotal gastrectomy - the stump of the stomach is anastomosed to the Jejunum • Total gastrectomy – GI continuity is restored by an anastomoiss b/n the ends of the esophagus and jejunum. 140
  • 141. Cont--- Other treatment includes • Chemotherapy • Radiation has little success in gastric Ca. 141
  • 142. Cont--- Nursing interventions 1) Preoperative care • Support the patient and family • Assess and document signs and symptoms and reaction to treatments • Provide and encourage the prescribed diet • Monitor vital signs at least Q 8 hrs • Monitor blood and fluid replacement therapy • Provide preparative teaching 142
  • 143. Cont--- 2) Post operative care • Have patient turn, cough and breathe deeply • Monitor NG suctioning and tube patency • Monitor vital signs as ordered • Record intake and out put • Administer prescribed medications and monitor for side effects 143
  • 144. Cont --- • Encourage early ambulation and Rome (rapid eye movement exercises to prevent thrombosis • Provide anti embolism and supportive measures • Analgesics if pain occurs, and supportive measures • Educate patient and family concerning drug therapy dietary restrictions, activity, 144
  • 145. Intestinal disorders Intestinal Obstruction • It exists when blockages prevents the normal flow of intestinal contents through the intestinal tract. • Two types of process can impede flow: 1) Mechanical obstruction - an intraluminal obstruction from pressure on the intestinal walls. 145
  • 146. Cont--  Mechanical obstruction can be caused by: • Intussusceptions: one part of the intestine slips in to the another part located below it like a telescope shortening. • Adhesions: loops of the intestine become adherent to areas that heal slowly or scar after abdominal surgery 146
  • 147. Cont--- • Volvlus: bowel twist and turns upon it • Hernias: protrusion of intestine through a weakened area in the abdominal muscle or wall. • Tumors, and neoplasm 147
  • 149. Cont--- 2) Functional obstruction: the intestinal musculature cannot propel the contents along the bowel. • E.g. muscular dystrophy, endocrine disorders such as DM, or neurological disorders such as Parkinson’s disease 149
  • 150. Cont--- • The obstruction can be partial or complete. • Its severity depends: • On the region of bowel affected • The degree to which lumen is occluded and • Especially the degree to w/c vascular supply is disturbed 150
  • 151. A) Small bowel obstruction (SBO) • Most bowel obstructions (85%) occur in the small intestine, Adhesion is the most common cause of SBO, followed by hernias and neoplasms. 151
  • 152. Cont---- Pathophysiology • In SBO, intestinal contents, fluid, and gas accumulate above the intestinal obstruction • The abdominal distension and retention of fluid reduce the absorption of fluids and Stimulate more gastric secretion • This caused edema, congestion, necrosis and eventually rupture or perforation of the intestinal wall, with resultant peritonitis. 152
  • 153. Cont--- • Reflux vomiting may be caused by abdominal distension • Dehydration and acidosis develop from loss of water and sodium. • With acute fluid losses hypovolemic shock may occur. 153
  • 154. Cont--- C/M- • Initially crampy pain that is wavelike and colicky. • blood and mucus may pass, but no fecal matter and no flatus. • Abdomen becomes distended 154
  • 155. Cont--- • If obstruction is complete- the peristaltic wave become reverse direction so intestinal content come to the mouth • If obstructions is in the ileum- fecal vomiting takes place • First the patient vomits the stomach contents then the bile stained contents of the duodenum and the jejunum and finally with each paroxysm of pain, the darker, fecal like contents of the ileum. 155
  • 156. Cont---  Sign of DHN become evident i.e. intense thirst • Drowsiness • Generalized malaise • abdominal distention • hypovolemic shock from DHN and loss of plasma volume and • constipation 156
  • 157. Cont--- Diagnostic Evaluation • patient Hx and P/E • X-ray findings (shows abnormal quantities of gas, fluid or both in the bowel) • Laboratory studies (electrolyte studies and CBC) 157
  • 158. Cont--- Management • Decompression of the bowel through a nasogastric tube is successful in most cases • Complete obstruction needs , surgical intervention /depends on the cause of obstruction i.e. – if adhesion dividing the adhesion to which intestine is attached , – if hernia: repairing of hernia. 158
  • 159. Cont--- • IV therapy to replace the depleted water, and electrolyte before surgery • prophylactic antibiotics • monitor intake and out put • supportive care 159
  • 160. Cont--- Nursing intervention • Maintaining the function of the NG tube • Assessing and measuring the nasogastric out put • Assessing for fluid and electrolyte imbalance • prepare the pt’ for surgery • Assess and document signs and symptoms and relations to treatments • Monitor V/S at least Q 4 hrs • Record intake and out put 160
  • 161. Cont--- • Administered prescribed medication and monitor for side effects • maintain NPO • monitor the state of distention and hydrations • provide routine post operative care if patient undergoes surgery 161
  • 162. B) Large bowel obstruction (LBO) • About 15% of intestinal obstruction occur in the large bowel and the most common cause are carcinoma, diverticulitis, inflammatory bowel diseases and benign tumors • Most are found in sigmoid colon. 162
  • 163. Cont---- • As in small bowel obstruction, large bowel obstruction results in an accumulation of intestinal contents, fluid and gas proximal to the obstruction. • Even if the obstruction is complete, it may be undramatic if the blood supply to the colon is not disturbed. • If the blood supply is cut off, however strangulation and necrosis (i.e. tissue death) occur, this condition is life threatening. 163
  • 164. c/ms • LBO differs clinically from small bowel obstruction in that Symptoms develop slowly relative to SBO • Constipation (if obstruction in sigmoid colon or the rectum). • Abdomen becomes markedly distended 164
  • 165. Cont--- • Loops of large bowel becomes visibly outlined through the abdominal wall. • Eventually, Crampy lower abdominal pain • Dehydration occurs more slowly than in the small intestine 165
  • 166. Cont--- Diagnosis • Based on symptoms • X-ray studies (show distended colon) • Barium enema is contraindicated. 166
  • 167. Cont--- Management • Colonoscopy may be performed to untwist and decompress the bowel. • Rectal tube to decompress. • The usual Rx, however, is surgical resection to remove the obstructing lesion. 167
  • 168. Cont--- • Cecostomy /surgical opening of the cecum / may be performed. • Temporary or permanent colostomy may be necessary /is the surgical creation of an opening into the colon to drainage or evacuation colon contents to the outside of the body. 168
  • 169. Acute inflammatory intestinal disorders. • Any part of the lower gastrointestinal tract is susceptible to acute inflammation caused by infection due to bacteria, virus, or fungus. • The two sever situations are appendicitis and diverticulitis. And others include peritonitis and gastroenteritis. 169
  • 170. A) Appendicitis • Appendix is a small, finger like appendage about 10 cm long that is attached to the cecum just below the ileocecal valve • Has no definite function • The appendix fills with food and empties regularly in to the cecum • Because it empties inefficiently and its lumen is small, the appendix is prone to obstruction and is particularly vulnerable to infection. 170
  • 171. Cont--- • Appendicitis: It is an inflammation of the appendix. • Is the most common cause of acute inflammation in the RLQ of abdominal cavity • Is the most common reason for emergency surgery. • People consume a diet low in fiber and high in refined carbohydrates are more liable 171
  • 172. CAUSES OF APPENDICITIS Traumatic injury to the abdomen Feces blocks the inside of appendix Genetics Genetic variant that predisposes a person to obstruction of the appendiceal lumen
  • 173. CAUSES OF APPENDICITIS Obstruction of the lumen by:  A fecalith (accumulated feces)  Foreign bodies  Worms (e.g., Pinworms, ascaris)  Intramural thickening caused by lymphoid hyperplasia  Tumors of the cecum or appendix  Kinking of appendix  Inflammation  Neoplasm
  • 174. pp Obstruction  Distension  Venous engorgement  Accumulation of mucus and bacteria (pus)  Gangrene  Perforation
  • 176. Cont--- C/M • Right lower quadrant pain and is usually accompanied by a low-grade fever and nausea and vomiting sometimes • Loss of appetite • Local tenderness noted in Mcburaey’s point. (Located ½ way b/n the umbilicus and the anterior spine of the ileum) 176
  • 178. 178
  • 179. Cont--- • If the appendix is has ruptured, the pain becomes more diffuse. • abdominal distention, develops as a result of paralytic illus . • Constipation can also occur • In general, laxative or cathartic should never be given while the person has fever nausea or pain. 179
  • 180. Diagnosis • Patient Hx • Lab studies particularly WBC count /elevated WBC. • X-ray findings • Physical examination 180
  • 181. Cont--- Tests of appendicitis • Rovsing’s sign • Rebound tenderness • Psoas sign • Obturator sign 181
  • 183. Psoas Sign: 2 methods 1st Method  Place your hand just above the patient’s right knee  Ask the patient to raise that thigh against your hand (extending right thigh) 2nd Method  Ask the patient to turn onto the left side  Then extend the patient’s right leg at the hip  Flexion of the leg at the hip makes the psoas muscle contract; extension stretches it 183
  • 184. 184
  • 185. Rovsing’s sign • Elicited by palpating the LLQ; this paradoxically causes pain to be felt in the RLQ 185
  • 186. Positive Obturator Sign  Flex the patient’s right thigh at the hip, with the knee bent, and rotate the leg internally at the hip  This maneuver stretches the internal obturator muscle If the appendix has ruptured  The pain becomes more diffuse  Abdominal distention develops  The patient’s condition worsens 186
  • 187. 187
  • 188. • Blumberg’s sign - The pain is elicited with pressing the abdominal wall deeply with fingers and abruptly releasing it. 188
  • 189. 189
  • 190. • < 4: Excludes diagnosis • 5-6: Equivocal • >7 : Strongly s/o appendicitis • Modified Alvorado Score: - 9 points - Differential count not done 190
  • 191. Tzanakis Score 1. Rt lower abdominal tenderness = 4 2. Rebound tenderness = 3 3. WBC’s> 12,000 in the blood = 2 4. Positive USS findings of appendicitis = 6 • Total score = 15 • > 8 = 96% chances
  • 192. Management 1) Supportive treatment • Correct fluid and electrolyte imbalance and DHN. • Antibiotics • If surgery is undecided avoid analgesic 2) Surgery: is indicated if appendicitis is diagnosed==>appendec tomy. 192
  • 193. Cont--- Complications • The major complication of appendicitis is perforation of the appendix, which can lead to peritonitis or abscess. • Incidence of perforation is 10-32% • It generally occurs 24hrs after the onset of pain. Symptoms include a fever of 37.7oC or higher, and continued abdominal pain or tenderness. 193
  • 194. B) Peritonitis • Peritoneum is the serous membrane lining the abdominal cavity and covering the viscera. • Peritonitis is an acute inflammation of the peritoneum • It can be classified as primary (as TB) and secondary (secondary to trauma, bile leakage ) and localized and generalized. 194
  • 195. Cont--- • It is commonly caused by the leakage of contents from abdominal organs into the abdominal cavity, and lead to contamination of peritoneal cavity by bacteria usually as a result of inflammation, infection, or trauma 195
  • 196. Etiology • Usually it is a result of bacterial infection, the organism come from disease of the GI tract ( e. coli, streptococcus, staphylococcus, etc ) or, in women, from the internal reproductive organs (Gonococcus). • Bacteria gain entry into the peritoneum by perforation or from external penetrating wound. 196
  • 197. Cont--- • The most common causes of bacteria peritonitis are appendicitis, perforation associated with PUD, diverticulitis, and bowel obstruction. • It can also result from external sources such as injury or trauma (ex. Gunshot wound, stab wound), or inflammation that extend from an organ outside peritoneal area. 197
  • 198. c/ms • It depends on the location and extent of inflammation • The cardinal signs of peritonitis are abdominal pain / tenderness localized or generalized) and progressive abdominal distention. • At first, diffuse type of pain is felt 198
  • 199. Cont--- • The pain tends to become constant, localized and more intense near the site of inflammation • The affected area of the abdomen becomes extremely tender and distended and the muscles become rigid. 199
  • 200. Cont--- others • fever • N/V/anorexia • diminished bowel sounds • inability to pass flatus and or feces • pulse rate increase • Dehydration • Respiratory difficulty 200
  • 201. Cont--- Diagnostic Evaluation • c/ms • lab, increase WBC(> 20,000/mm3) • abdominal X-ray • Peritoneal dialysis (positive for peritonitis if more than 500 WBC/ml of fluid or more than 50,000 RBCs/ml of fluid or Presence of bacteria ) 201
  • 202. Management • Hospitalization • Fluid, and electrolyte replacement is the major focus. • Iv fluids • Analgesics are prescribed for pain • Broad spectrum antibiotics therapy • NG tube is inserted to decompress the stomach and intestine and the client is on NPO status • Oxygen if respiratory distress. 202
  • 203. Cont--- • Positioning: semi fowlers position to promote drainage of peritoneal contents in to inferior region and abdominal cavity and also to it facilitate adequate respiration. • Surgical if critically needed: exploratory laparotomy ; to remove or repair the inflamed or perforated organ; 203
  • 204. Cont--- Complication • Sepsis is the major cause of death from peritonitis • Shock – from septicemia or hypovolemia • Intestinal obstruction – from inflammatory process 10 from development of bowel adhesions 204
  • 205. C) Diverticulitis • Diverticula are congenital or acquired pouch like herniations of the mucosa through the muscular wall of the small intestine or colon. • Diverticula can occur in any part of the small or large intestine but they occur most commonly in the sigmoid colon. 205
  • 206. Cont--- • Diverticulosis is the presence of many diverticula without inflammation or symptoms. • Diverticulitis is the term used to describe an inflammation of one or more diverticula, 206
  • 207. Causes • It forms when the mucosa and sub mucosal layer of the colon herniated through the muscular wall because of • High intraluminal (abdominal) pressure and • Decreased muscle strength in the colon wall (i.e. muscular hypertrophy from hardened fecal masses or w/n blood supply interrupt ). • Chronic constipation precedes the development of diverticulosis by many years • Eating diet with small fiber can increased the risk of diverticula. 207
  • 208. Cont--- • Undigested foods or bacteria can become trapped in the diverticulum = diverticulum becomes inflamed and local abscess forms = diverticulitis • Abscess develops and may eventually perforate, = leading to peritonitis 208
  • 209. Cont--- C/M • Bowel irregularity and intervals of diarrhea • Abrupt onset of crampy pain in the LQ • Fever • V/N, anorexia and abdominal distension • Bleeding • If untreated, septicemia develop 209
  • 210. Cont--- Dx • Occult blood test /FOBT • x –ray 210
  • 211. Management • Combination of drug and diet therapy with rest to decrease inflammation and to improve tissue perfusion. • When symptoms occur, rest, analgesics and antispasmodics are recommended • Initially, the diet is clear liquid until the inflammation subsides: then a high fiber, low- fat diet is recommended. 211
  • 212. Cont--- • Broad spectrum antibiotics e.g. metrindazole + Cotrimoxazole, anti pains and anticholinergics (to reduce intestinal motility) are recommended • enema and laxatives are avoided = increase intestinal motility • encourage to avoid activities that increase abdominal pressure e.g. straining, bending, lifting etc 212
  • 213. Cont--- • Surgical management :- immediate surgical intervention is necessary if complications (Ex. Perforation/rupture , abscess formation, hemorrhage, peritonitis and bowel obstruction) 213
  • 214. D) Gastro enteritis • Is an increase in the frequency and water contents of stool or vomiting as result of the inflammation of mucous membrane of the intestinal tract and stomach • It can be viral (e.g. rota virus) or bacterial ( e.g. E.coli, shigellosis, ameobiasis,) in origin. • Usually self limiting if no complication 214
  • 215. Cont--- Mgt • Treatment of the c/ms plus • drug mgt depends on the lab result • e.g. if bacterial Abs ( Norfloxacillin 400mg PO BID, or ciprofloxacilin 500mg PO BID for 3days) • If viral only supportive treatment (Rx of DHN, antiemetic, anticholenergis to suppress intestinal motility) 215
  • 216. Chronic inflammatory Bowel Disease (IBD) • Is disorders of the lower GIT, and it refers to two chronic inflammatory GI disorders:- –Ulcerative colitis –Regional enteritis (crohn’s disease) 216
  • 217. A) Ulcerative Colitis • Is a recurrent ulcerative and inflammatory disease of the mucosal and sub mucosal layers of the colon and rectum with unknown etiology. • Sometimes following bowel infection, Autoimmune (antibody against bowel epithelium) can be a contributory factors 217
  • 218. Cont--- • It affects the superficial mucosa of the colon and is characterized by multiple ulcerations, diffuse inflammations • Bleeding occurs as a result of the ulcerations. • The mucosa becomes edematous and inflamed • The disease process usually begins in the rectum & spreads proximally to involve the entire colon. 218
  • 219. Cont--- • Is a serious disease accompanied by systemic complication and high mortality rate. • Eventually 10-15 % of the pt develop carcinoma of the colon. • Peak incidence 30-50yrs. 219
  • 220. Cont--- C/M • Diarrhea(10 to 20 times /day), • LLQ abdominal pain, • intermittent tensemus and rectal bleeding are the predominant symptoms. 220
  • 221. Cont--- Others: May have anorexia, wt loss, fever, vomiting and dehydration, as well as cramping, the feeling of an urgent need to defecate . • Hypocalcemia & anemia frequently develop. • Rebound tenderness may occur in the right lower quadrant (suggests peritonitis) 221
  • 222. Cont--- Diagnostic evaluation • Stool is +ve for blood • Low Hgb and HCT and increases WBC • X-ray (abdominal) • Sigmodoscopy, or colonoscopy • Stool examination for parasites and other microbes (to rule out dysentery caused by common intestinal organisms like E.histolytica) 222
  • 223. Management Nutritional therapy • Oral fluids,high protein, high-calories diet with supplemental vitamin therapy and iron replacement are prescribed to meet nutritional needs, reduce inflammation, and control pain and diarrhea • Any foods that exacerbate diarrhea are avoided ex. Milk, may contribute to diarrhea in those with lactose intolerance. 223
  • 224. Cont--- Pharmacologic therapy • Antidiarrheal & anti peristaltic medications are used to minimize peristalsis to rest the inflamed bowel • Aminosalicylate formulations are often effective for mild or moderate inflammation • Corticosteroids are used to treat severe disease 224
  • 225. Cont--- • Surgical management may recommend when medical measurement fail to relive the severe symptoms. • e.g. total proctocolectomy /colectomy with permanent ileostomy =>The colon rectum and anus are removed and followed by closure of anus. 225
  • 226. B) Regional Enteritis /crohn’s disease • An inflammatory diseases of the small intestine (60%) and colon or both. • it involves all layers of the bowel but most commonly involves the terminal ileum. • It results in sever diarrhea and mal absorption of vital nutrients. 226
  • 227. c/ms • In RE, the onset of symptoms is usually insidious • abdominal pain and diarrhea unrelieved by defecation • Crampy abdominal pain • Abdominal tenderness and spasm • Since eating stimulates peristalsis, the crampy pain occur after meals • Weight loss as a reason of to avoids the crampy pain, malnutrition and secondary anemia. 227
  • 229. Comparison b/n RE and UC Ulcerative colitis • Begins in the rectum and proceeds in a continuous manner toward the colon • Etiology: Un known • 10-20 liquid bloody stool per day Regional enteritis • Most often in the terminal ileum with patchy involvement through all layers of the bowel • Un known • 5-6 soft loose stools per day rarely bloody 229
  • 230. Cont--- Ulcerative colitis • Complications: Hemorrhage, perforation, fistula and nutritional deficiency Regional enteritis • Fistula and nutritional deficiency 230
  • 231. Cancer of large intestine colon and rectum • The exact cause of colon and rectal cancer is unknown.  but the risk factors including • family history colon CA, • history of chronic inflammatory diseases • Age – over 40 , • Diet –high in fat, protein, beef, and low in fiber . 231
  • 232. Cont--- Distribution of cancer site throughout the colon • 22% in ascending colon, • 11% transverse colon, • 6% descending colon, • 33% sigmoid colon and in 27% rectum 232
  • 235. Clinical manifestations • Changes in bowel habits (most common) • The passage of blood in the stools (2nd most common) • Rectal/ abdominal pain, • Tensmus and feeling of incomplete emptying after bowel mov’t.  Symptoms may include also • Unexplained anemia • Wt loss , fatigue and dull abdominal pain 235
  • 236. Cont--- • N.B any patient with a history of unexplained change in bowel habit, with passage of blood in the stools should be studied carefully to rule out cancer of the large bowel. 236
  • 237. Diagnostic Evaluation • Abdominal and rectal examination • Fecal occult blood testing (most important) • Procto sigmoidoscopy and colonoscopy with biopsy or cytological smear) • X-ray 237
  • 238. Management • Chemotherapy (anti carcinogenic drugs: IV-5 fluorouracil (5-FU), with or without Leucovorin , potent analgesics) • Radiation therapy and supportive therapy • Surgical resection of the affected area with anastomosis /creation of a colostomy(fecal diversion) if necessary : permanent or temporarily colostomy, collectomy (colon removal ) 238
  • 239. Disease of the Anorectum • Anorectal disorders are common. It includes • Anal Fissure • anal fistula • Anorectal Abscess and • Hemorrhoids 239
  • 240. Anal Fissure • Is a longitudinal tear or ulceration in the lining of the anal canal • They are usually caused by the trauma of passing a large, firm stool or from persistent tightening of the anal canal because of stress and anxiety 240
  • 241. Cont--- Other causes includes • Child birth • Trauma and • Over use of laxatives c/ms • Extreme painful defection, burning and bleeding characterize fissures. 241
  • 242. Cont--- • Most of these fissures heal if treated by conservative measures, w/c include stool softeners , an increase in water intake, sitz bath and suppositories. • If fissures do not respond to conservative Rx, surgery is indicated. • The anal sphincter is dilated and the fissure is excised. 242
  • 243. Anal fistula • An anal fistula is a tiny, tubular, fibrous tract that extends into the anal canal from anal an opening located beside the anus. • Fistulas usually result from an infection. • They may also develop from trauma, fissures or regional enteritis (RE) and obstructed labuor in mother 243
  • 244. C/ms • Pus or stool may leak constantly from the cutaneous opening. • Other symptoms may be the passage of flatus or feces from the vaginal or bladder depending on the fistula tract. • Untreated fistula may cause systemic infection with related symptoms . 244
  • 245. Mgt • Surgery is always recommended. • Fistulectomy /excision of the fistulous tract • Keep the pt NPO and rehydrate with IV 245
  • 246. Hemorrhoids • Are dilated portions of veins in the anal canal. • They are very common. • By the age of 50, 50% of people have hemorrhoids to some extent 246
  • 247. Predisposing factors • Increased intra abdominal pressure in the hemorrhoid tissue pregnancy, constipation, internal abdominal tumors = pressure in rectal and anus veins = dilation occurs 247
  • 248. Cont--- They are classified into two types:- • Internal hemorrhoids:- if it occurs above the internal sphincter • External hemorrhoids: - those appearing outside the external sphincter. 248
  • 249. Fig. Internal and external hemorrhoids 249
  • 250. C/ms • Hemorrhoids cause itching and pain and are the most common cause of bright red bleeding with defection • Feeling of mass or pressure in the anal canal. • Edema and inflammation 250
  • 251. Cont--- • External hemorrhoids: are associated with severe pain from the inflammation and edema caused by thrombosis(i.e. clotting of blood within the hemorrhage) • Internal hemorrhoids: are not usually painful until they bleed or prolapsed when they became enlarged 251
  • 252. Management • It can be relieved by good personal hygiene, and by avoiding excessive straining during defecation • A high residue diet and increased fluid intake. • Laxatives , suppositories • Warm compress, Sitz bath and bed rest 252
  • 253. Cont--- Surgical Rx is applied according to the progress. • The rubber band legation procedure: the hemorrhoid portion above the mucocutaneous lines is grasped with an instrument and a small rubber band is then supplied over the hemorrhoids , the tissue becomes necrotic after several days and sloughs off. 253
  • 254. Cont--- • Hemorrhoidectomy, or surgical excision: can be performed to remove all the redundant tissue 254
  • 255. Reading assignment Hernia • Inguinal hernia • umbilical hernia • Incisional hernia • Abdominal hernia • Esophageal / diaphragmatic hernia 255
  • 256. . • Group Assignment on Pancreatic, hepatic and billary disorders
  • 257. Group Assignment and presentation on Pancreatic, hepatic and billary disorders  Group 1 and 6: [Liver] • Hepatitis • Liver cirrhosis  Group 2 and 4 : [Liver and pancreas] • Liver abscess and • Pancreatitis  Group 3 and 5 : [Billary] • Cholecystitis and • Cholelithiasis
  • 258. Outlines of the assignment • Definition • Epidemiology • Pathopsiology (if any) • Etiology/cause and or risk factors • Clinical manifestations • Diagnosis • Management • Nursing intervention • Prevention and control measures
  • 261. 261
  • 262. Jaundice • When the bilirubin concentration in the blood is abnormally elevated, all the body tissues, including the sclerae and the skin, become tinged yellow or greenish-yellow, a condition called jaundice. • Jaundice becomes clinically evident when the serum bilirubin level exceeds 2.5 mg/dL. 262
  • 263. Cont’d….. • Increased serum bilirubin levels and jaundice may result from impairment of hepatic uptake, conjugation ofbilirubin, or excretion of bilirubin into the biliary system. • There are several types of jaundice: hemolytic, hepatocellular, and obstructive jaundice, and jaundice due to hereditary hyperbilirubinemia. • Hepatocellular and obstructive jaundice are the two types commonly associated with liver disease. 263
  • 264. Hemolytic Jaundice • Hemolytic jaundice is the result of an increased destruction of the red blood cells, the effect of which is to flood the plasma with bilirubin so rapidly that the liver, although functioning normally, cannot excrete the bilirubin as quickly as it is formed. • This type of jaundice is encountered in patients with hemolytic transfusion reactions and other hemolytic disorders. 264
  • 265. Hepatocellular Jaundice • Hepatocellular jaundice is caused by the inability of damaged liver cells to clear normal amounts of bilirubin from the blood. • The cellular damage may be caused by hepatitis viruses, other viruses that affect the liver (eg, yellow fever virus, Epstein-Barr virus), medications or chemical toxins (eg, carbon tetrachloride, chloroform, phosphorus, arsenicals, certain medications), or alcohol. 265
  • 266. Obstructive Jaundice • Obstructive jaundice resulting from extrahepatic obstruction may be caused by occlusion of the bile duct from a gallstone, an inflammatory process, a tumor, or pressure from an enlarged organ (eg, liver, gallbladder). Hereditary Hyperbilirubinemia • Increased serum bilirubin levels (hyperbilirubinemia), resulting from any of several inherited disorders, can also produce jaundice. 266
  • 267. Portal Hypertension • Portal hypertension is the increased pressure throughout the portal venous system that results from obstruction of blood flow through the damaged liver. • Commonly associated with hepatic cirrhosis, it can also occur with non-cirrhotic liver disease. • Although splenomegaly (enlarged spleen) with possible hypersplenism is a common manifestation of portal hypertension, the two major consequences of portal hypertension are ascites and varices. 267
  • 269. Clinical Manifestations • Increased abdominal girth and rapid weight gain are common presenting symptoms of ascites. • The patient may be short of breath and uncomfortable from the enlarged abdomen, and striae and distended veins may be visible over the abdominal wall. • Umbilical hernias also occur frequently in those patients with cirrhosis. • Fluid and electrolyte imbalances are common. 269
  • 270. Management • Dietary modification- The goal of treatment for the patient with Ascites is a negative sodium balance to reduce fluid retention. Diuretics • Use of diuretics along with sodium restriction is successful in 90% of patients with ascites. • Spironolactone (Aldactone), an aldosterone-blocking agent, is most often the first-line therapy in patients with ascites from cirrhosis. • When used with other diuretics, spironolactone helps prevent potassium loss. • Oral diuretics such as furosemide (Lasix) may be added but should be used cautiously, because long-term use may induce severe sodium depletion (hyponatremia). 270
  • 271. Bed Rest • In patients with ascites, an upright posture is associated with activation of the renin–angiotensin– aldosterone system and sympathetic nervous system • This causes reduced renal glomerular filtration and sodium excretion and a decreased response to loop diuretics. • Therefore, bed rest may be a useful therapy, especially for patients whose condition is refractory to diuretics. • Paracentesis 271
  • 272. Transjugular Intrahepatic Porto systemic Shunt • TIPS-is a method of treating ascites in which a cannula is threaded into the portal vein by the transjugular route (Fig. 39-6). • Toreduce portal hypertension, an expandable stent is inserted to serve as an intrahepatic shunt between the portal circulation and the hepatic vein. 272
  • 273. Hepatic Encephalopathy and Coma • It is called portosystemic encephalopathy (PSE) • Is a life-threatening complication of liver disease that occurs with profound liver failure. Patients with this condition have no overt signs of the illness but do have abnormalities on neuropsychologic testing 273
  • 274. Clinical Manifestations • The earliest symptoms of hepatic encephalopathy include minor mental changes and motor disturbances. • The patient appears slightly confused and unkempt and has alterations in mood and sleep patterns. 274
  • 275. Cont’d……. • The patient tends to sleep during the day and has restlessness and insomnia at night. • As hepatic encephalopathy progresses, the patient may become difficult to awaken and completely disoriented with respect to time and place. • With further progression, the patient lapses into frank coma and may have seizures. • Asterixis (flapping tremor of the hands) may be seen in stage II encephalopathy 275
  • 276. HEPATIC CIRRHOSIS • Cirrhosis is a chronic disease characterized by replacement of normal liver tissue with diffuse fibrosis that disrupts the structure and function of the liver. 276
  • 277. • There are three types of cirrhosis or scarring of the liver: Alcoholic cirrhosis, in which the scar tissue characteristically surrounds the portal areas. This is most frequently caused by chronic alcoholism and is the most common type of cirrhosis. Postnecrotic cirrhosis, in which there are broad bands of scar tissue. This is a late result of a previous bout of acute viral hepatitis. Biliary cirrhosis, in which scarring occurs in the liver around the bile ducts. This type of cirrhosis usually results from chronic biliary obstruction and infection (cholangitis); it is much less common than the other two types. 277
  • 278. • The portion of the liver chiefly involved in cirrhosis consists of the portal and the periportal spaces, where the bile canaliculi of each lobule communicate to form the liver bile ducts. These areas become the sites of inflammation, and the bile ducts become occluded with inspissated (thickened) bile and pus. 278
  • 279. • The liver attempts to form new bile channels; hence, there is an overgrowth of tissue made up largely of disconnected, newly formed bile ducts and surrounded by scar tissue. 279
  • 280. Clinical Manifestations • Signs and symptoms of cirrhosis increase in severity as the disease progresses. • Their severity is used to categorize the disorder as compensated or decompensated cirrhosis 280
  • 281. • Compensated cirrhosis, with its less severe, often vague symptoms, may be discovered secondarily at a routine physical examination • The hallmarks of decompensated cirrhosis result from failure of the liver to synthesize proteins, clotting factors, and other substances and manifestations of portal hypertension 281
  • 282. 282
  • 283. • Liver Enlargement • Early in the course of cirrhosis, the liver tends to be large, • and the cells are loaded with fat. The liver is firm and has a • sharp edge that is noticeable on palpation. Abdominal pain • may be present because of recent, rapid enlargement of the • liver, which produces tension on the fibrous covering of the • liver (Glisson’s capsule). Later in the disease, the liver decreases • in size as scar tissue contracts the liver tissue. The • liver edge, if palpable, is nodular. 283
  • 284. • Portal Obstruction and Ascites • Portal obstruction and ascites, late manifestations of cirrhosis, • are caused partly by chronic failure of liver function and • partly by obstruction of the portal circulation. 284
  • 285. • Infection and Peritonitis • Bacterial peritonitis may develop in patients with cirrhosis • and ascites in the absence of an intra-abdominal source of • infection or an abscess. This condition is referred to as • spontaneous bacterial peritonitis (SBP). Bacteremia due to • translocation of intestinal flora is believed to be the most • likely route of infection. 285
  • 286. • Gastrointestinal Varices • The obstruction to blood flow through the liver caused by • fibrotic changes also results in the formation of collateral • blood vessels in the GI system and shunting of blood from • the portal vessels into blood vessels with lower pressures 286
  • 287. • Edema • Another late symptom of cirrhosis is edema, which is attributed • to chronic liver failure. A reduced plasma albumin concentration • predisposes the patient to the formation of • edema. 287
  • 288. • Vitamin Deficiency and Anemia • Because of inadequate formation, use, and storage of certain vitamins (notably vitamins A, C, and K), signs of deficiency are common, particularly hemorrhagic phenomena associated with vitamin K deficiency. 288
  • 289. • Mental Deterioration • Additional clinical manifestations include deterioration of • mental and cognitive function with impending hepatic encephalopathy • and hepatic coma, as previously described 289
  • 290. Management • Antacids or histamine-2 (H2) antagonists are prescribed to decrease gastric distress and minimize the possibility of GI bleeding. • Vitamins and nutritional supplements promote healing of damaged liver cells and improve the patient’s general nutritional status. • Potassium-sparing diuretics such as spironolactone or triamterene (Dyrenium) may be indicated to decrease ascites, if present; these diuretics are preferredbecause they minimize the fluid and electrolyte changescommonly seen with other agents 290
  • 291. Nursing Management • Promoting Rest • Reducing Risk of Injury • Improving Nutritional Status • Providing Skin Care • Monitoring and Managing Potential Complications  Fluid Volume Excess  Hepatic Encephalopathy  Bleeding and Hemorrhage • The patient is at increased risk for bleeding and hemorrhage because of decreased production of prothrombin and decreased ability of the diseased liver to synthesize the necessary substances for blood coagulation. 291
  • 292. DISORDERS OF THE GALLBLADDER • Gallbladder disease with gallstones is the most common disorder of the biliary system. • Although not all occurrences of gallbladder inflammation (cholecystitis) are related to gallstones (cholelithiasis), more than 90% of patients with acute cholecystitis have gallstones. 292
  • 293. 293
  • 294. Cholecystitis • Cholecystitis, acute inflammation of the gallbladder, causes pain, tenderness, and rigidity of the upper right abdomen that may radiate to the midsternal area or right shoulder and is associated with nausea, vomiting, and the usual signs of an acute inflammation. • An empyema of the gallbladder develops if the gallbladder becomes filled with purulent fluid (pus). 294
  • 295. Cont…. • In calculous cholecystitis, a gallbladder stone obstructs bile outflow. • Bile remaining in the gallbladder initiates a chemical reaction; autolysis and edema occur; and the blood vessels in the gallbladder are compressed, compromising its vascular supply. • Gangrene of the gallbladder with perforation may result. • Bacteria play a minor role in acute cholecystitis; however, secondary infection of bile occurs in approximately 50% of cases. 295
  • 296. • The organisms involved • are generally enteric (normally live in the GI tract) and include • Escherichia coli, Klebsiella species, and Streptococcus. • Bacterial contamination is not believed to stimulate the actual • onset of acute cholecystitis ( 296
  • 297. 297
  • 298. Cholelithiasis • Calculi, or gallstones, usually form in the gallbladder from the solid constituents of bile; they vary greatly in size, shape, and composition (Fig. 40-2). • They are uncommon in children and young adults but become more prevalent with increasing age, affecting 30% to 40% of people by the age of 80 years. 298
  • 299. Pathophysiology • There are two major types of gallstones: those composed • predominantly of pigment and those composed primarily of • cholesterol. Pigment stones probably form when unconjugated • pigments in the bile precipitate to form stones; these • stones account for about 10% to 25% of cases in the United • States (Feldman, et al., 2006). The risk of developing such • stones is increased in patients with cirrhosis, hemolysis, and • infections of the biliary tract. Pigment stones cannot be dissolved • and must be removed surgically. 299
  • 300. • Cholesterol stones account for most of the remaining • 75% of cases of gallbladder disease in the United States. • Cholesterol, a normal constituent of bile, is insoluble in water. • Its solubility depends on bile acids and lecithin (phospholipids) • in bile. In gallstone-prone patients, there is decreased • bile acid synthesis and increased cholesterol • synthesis in the liver, resulting in bile supersaturated with • cholesterol, which precipitates out of the bile to form • stones. 300
  • 301. • Two to three times more women than men develop cholesterol • stones and gallbladder disease; affected women are • usually older than 40 years of age, multiparous, and obese. • Stone formation is more frequent in people who use oral • contraceptives, estrogens, or clofibrate; these medications • are known to increase biliary cholesterol saturation. 301
  • 302. 302
  • 303. Clinical Manifestations • Gallstones may be silent, producing no pain and only mild • GI symptoms. Such stones may be detected incidentally • during surgery or evaluation for unrelated problems. 303
  • 304. • The patient with gallbladder disease resulting from gallstones • may develop two types of symptoms: those due to • disease of the gallbladder itself and those due to obstruction • of the bile passages by a gallstone. The symptoms may be • acute or chronic. Epigastric distress, such as fullness, abdominal • distention, and vague pain in the right upper quadrant • of the abdomen, may occur. This distress may follow a • meal rich in fried or fatty foods. 304
  • 305. • Pain and Biliary Colic • Jaundice • Changes in Urine and Stool Color • Vitamin Deficiency 305
  • 306. Assessment and Diagnostic Findings • Abdominal X-Ray • Ultrasonography • Cholecystography 306
  • 307. Medical Management • The major objectives of medical therapy are to reduce the • incidence of acute episodes of gallbladder pain and cholecystitis • by supportive and dietary management and, if possible, • to remove the cause of cholecystitis by pharmacologic • therapy, endoscopic procedures, or surgical intervention. 307
  • 308. • Although nonsurgical approaches eliminate risks associated • with surgery, these approaches are associated with persistent • symptoms or recurrent stone formation. Most of the nonsurgical • approaches, including lithotripsy and dissolution of • gallstones, provide only temporary solutions to gallstone • problems and are infrequently used in the United States. In • some instances, other treatment approaches may be indicated; • these are described later. 308
  • 309. • Removal of the gallbladder (cholecystectomy) through • traditional surgical approaches was the standard treatment • for more than 100 years. It has largely been replaced by laparoscopic • cholecystectomy (removal of the gallbladder • through a small incision through the umbilicus). As a result, • surgical risks have decreased, along with the length of • hospital stay and the long recovery period required after • standard surgical cholecystectomy. In relatively rare instances, • a standard surgical procedure may be necessary. 309
  • 310. • Nutritional and Supportive Therapy • Approximately 80% of the patients with acute gallbladder • inflammation achieve remission with rest, IV fluids, nasogastric • suction, analgesia, and antibiotic agents. Unless the • patient’s condition deteriorates, surgical intervention is delayed • just until the acute symptoms subside (usually within • a few days). At this time, the patient should undergo a laparoscopic • cholecystectomy 310
  • 311. • Pharmacologic Therapy • Ursodeoxycholic acid (UDCA [URSO, Actigall]) and chenodeoxycholic • acid (chenodiol or CDCA [Chenix]) have • been used to dissolve small, radiolucent gallstones composed • primarily of cholesterol. 311
  • 312. 312

Editor's Notes

  1. Fungus leave as a normal flora in immuno-competent pt with limited growth (there growth is limited by bacteria's in wait area and by natural dryness in skin, moist favor their growth) Mucosal, skin, systemic , (systemic is fatal but rare)
  2. 40% of cases has family history of oral ulcer
  3. No therapy is curative only alleviating the symptoms
  4. Syrup is preferable (it will have a topical effect)
  5. Pain 1st vomiting 2nd fever 3rd
  6. 1) Rebound tenderness: sever pain on quickly withdrawing of the palpating hand from the RLQ 2) Check for Rovsing’s sing: Pain in the right lower guardant during left- sided pressure suggests appendicitis (a positive Rovsing’s sign). 3) Look for psoas sign: Place your hand just above the patient’s right knee and ask the patient to raise the thigh against your hand. Increased abdominal pain on this maneuver constitutes a positive psoas sign, suggesting irritation of the psoas muscle by an inflamed appendix. 4) Obturator sign: rotate leg internally and external with flexed hip and knee: right hypo gastricpain = positive obturator sign
  7. The vasodilation that occurs in the splanchnic circulation (the arterial supply and venous drainage of the GI system from the distal esophagus to the midrectum including the liver and spleen) is also a suspected causative factor. The failure of the liver to metabolize aldosterone increases sodium and water retention by the kidney. Sodium and water retention, increased intravascular fluid volume, increased lymphatic flow, and decreased synthesis of albumin by the damaged liver all contribute to the movement of fluid from the vascular system into the peritoneal space. The process becomes self-perpetuating; loss of fluid into the peritoneal space causes further sodium and water retention by the kidney in an effort to maintain the vascular fluid volume. As a result of liver damage, large amounts of albuminrich fluid, 15 L or more, may accumulate in the peritoneal cavity as ascites. (Ascites may also occur with disorders such as cancer, kidney disease, and heart failure.) With the movement of albumin from the serum to the peritoneal cavity, the osmotic pressure of the serum decreases. This, combined with increased portal pressure, results in movement of fluid into the peritoneal cavity (Fig. 39-4).